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Max W. Adolphs 
THE VALIDITY AND RELIABILITY OF THE PAVS AND IPAQ-SF AS PHYSICAL 
ACTIVITY ASSESSMENT TOOLS IN PATIENTS WITH OBSTRUCTIVE SLEEP 
APNEA  
Efforts to encourage the medical community to prescribe exercise for disease 
prevention and management have increased significantly in recent years.  In patients with 
obstructive sleep apnea (OSA), it is encouraging that exercise has been shown to improve 
sleep efficiency, daytime sleepiness, and disease severity.  However, in order to better 
understand the dose-response relationship between exercise and OSA-related outcomes, 
accurate and reliable methods for assessing physical activity habits are needed.  Purpose: 
To determine the test-retest reliability and validity of two self-report physical activity 
questionnaires [Physical Activity Vital Sign (PAVS); International Physical Activity 
Questionnaire-Short Form (IPAQ-SF)] in an OSA population.  Methods: 39 adults with 
moderate-to-severe OSA wore an accelerometer for seven consecutive days and 
completed the PAVS and IPAQ-SF (twice within 10 d), along with questionnaires on 
quality of life, sleepiness, and treatment adherence. Test-retest reliability was determined 
using intraclass correlation coefficients (ICC). Criterion and construct validity were 
determined using Pearson (r) and Spearman correlation coefficients (ρ), respectively.  
Results: PAVS and IPAQ-SF scores were reported as total min/wk of moderate-vigorous 
physical activity (MVPA).  Test-retest reliability for MVPA was excellent for PAVS 
(ICC = 0.982) and good for IPAQ-SF (ICC = 0.766). MVPA assessed via accelerometry 
was strongly correlated with PAVS (r = 0.802) and moderately with IPAQ-SF (r = 
0.569). Both PAVS and IPAQ-SF were significantly correlated with body mass index 
iv 
(BMI) (ρ = -0.273 and -0.268, respectively), but no other variables. Conclusions: The 
PAVS and IPAQ-SF are reliable and valid PA questionnaires and may be utilized as a 
tool for accurately assessing physical activity levels in OSA patients. 
Anthony Kaleth, PhD., Chair 
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Chapter 1: Introduction to the Study 
Introduction  
Obstructive sleep apnea (OSA) is a major public health problem characterized by 
periods of partial or complete upper airway collapse during sleep (Eckert & Malhotra, 
2008). The decreased airflow often leads to acute hypoxia and awakening from sleep 
(Eckert & Malhotra, 2008). These sleep-mediated disruptions in airflow often acutely 
cause loud snoring, repeated stressful arousals to re-establish breathing, and excessive 
daytime sleepiness.  If left untreated, the long-term consequences of OSA are 
considerable, complex, and multisystemic.  
Regarding long-term consequences, OSA is associated with debilitating effects on 
daily function and quality of life, including impaired cognitive function, depression, and 
increased health care use (Punjabi, 2008).  Most importantly, however, is the fact that 
OSA substantially increases risks for major cardiovascular and metabolic disorders, and 
predisposes individuals to increased mortality (Peppard et al., 2000; Peker et al., 2006; 
Punjabi & Polotsky, 2006). Although exact costs are difficult to gauge, OSA creates a 
substantial economic burden, with estimates upwards of $100 billion per year (Knauert et 
al., 2015). 
Early data from the Wisconsin Sleep Cohort Study indicated a relatively low 
prevalence of OSA (2% to 4%) among middle-aged adults (Skomro & Kryger, 1999).  
However, over the past two decades, improved techniques for the evaluation of OSA 
have been developed and clinicians are increasingly aware of the seriousness of this 
disorder (Peppared et al., 2013).  Subsequent research on OSA prevalence now shows 
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much higher rates among both women (3% to 9%) and men (10% to 17%) (Peppared et 
al., 2013).   
While there are many causes of OSA, one of the greatest risk factors is excess 
body weight. The relationship between excess body weight and OSA can be seen when 
examining sleep test data, which has shown that over 60% of patients referred for sleep 
tests are overweight (Coughlin et al., 2004; Quan et al., 2007; Redline et al., 2003; Young 
et al., 1993; Strohl & Redline, 1996;). It has become well accepted that there is a direct 
relationship between excess body weight, physical inactivity, and OSA (Coughlin et al., 
2004; Quan et al., 2007; Redline et al., 2003, Tishler et al., 2003; Simpson et al., 2015).  
The fact that excess body weight causes OSA is particularly problematic because 
excess body weight is known to increase the risk for the development of cardiovascular 
and metabolic disorders, similarly to OSA. Additionally, if OSA is developed due to 
excess body weight, it is possible that the presence of OSA will further decrease physical 
activity levels and increase weight gain through daytime sleepiness and cognitive 
dysfunction, resulting in a vicious cycle which exacerbates the risk of developing or 
worsening existing OSA, cardiovascular disease, and metabolic disorders (Simpson et al., 
2015). Taken as a whole, these facts have made it difficult to understand if the 
cardiovascular and metabolic disorders seen in OSA patients are a product of obesity, 
OSA, or a combination of both.  
The present protocol for treating OSA consists of using continuous positive 
airway pressure (CPAP), which applies continuous pressure to keep the airways open 
during sleep. While CPAP is effective in treating the side effects of OSA, issues exist in 
its use. The first being that adherence rates remain unacceptably low, ranging between 
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17% and 85% (Sin et al., 2002; Weaver & Grunstein, 2008; Wolkove et al., 2008; 
Wozinak et al., 2014). The second and most notable for the interests of this study is that 
CPAP use does not increase activity levels or decrease body weight, and may even 
increase body weight (Drager, et al., 2015).  
A meta-analysis by Drager and colleagues (2015) examined the influence of 
CPAP on body weight in those with OSA. They identified 25 separate studies which used 
CPAP versus controls for a minimum treatment duration of 4 weeks. These studies 
included a total of 3,181 patients, most of whom were overweight or obese. The analysis 
concluded that CPAP does not decrease body weight and actually results in increases in 
BMI with no single predictor for the cause. In this regard, combining recommendations 
for exercise and physical activity with CPAP may be a viable means to increase daily 
energy expenditure in patients with OSA, as well as reduce secondary risk factors that 
place patients at increased risk for worsening of their OSA symptoms and for 
cardiovascular disease.  
Physical activity is known to have many health benefits, including body weight 
maintenance and reduction, throughout many populations (Miller et al., 1997). Numerous 
studies have examined the effects of physical activity on OSA patients, most of whom 
were overweight or obese, and demonstrated that increased physical activity levels result 
in body weight maintenance or reduction combined with significant reductions in OSA 
severity (Giebelhaus et al. 2000; Ueno et al., 2009; Kline et al., 2011; Sengul et al., 
2011). Importantly, studies have found that increases in physical activity reduce OSA 
severity even when body weight reductions are not realized (Kline et al., 2011; Sengul et 
al., 2011). For example, a study by Sengul and colleagues (2011) recruited patients with 
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moderate OSA and randomized them into exercise and control groups. The exercise 
group, which performed aerobic exercise three times per week for 1.5 hours per day, saw 
the number of apnea hypopnea events significantly reduced when compared to the control 
group. Importantly, this reduction was realized without any reductions in body weight.  
The results of the studies examining exercise within OSA patients indicate that 
interventions to increase physical activity levels would be beneficial for anyone with 
OSA, but especially for those who are overweight, obese, and/or receiving CPAP 
treatment. Thus, gauging physical activity levels of OSA patients is important for both 
researchers and clinicians who aim to understand and, when appropriate, increase 
physical activity levels of their patients.  
Background of the Problem  
Many research studies and clinical settings currently gauge OSA patient physical 
activity levels through self-report questionnaires (Bamberga et al., 2015; Batool Anwar et 
al., 2014; and Jean et al., 2017; and West et al., 2009). This is a troubling fact because, 
while many physical activity questionnaires have been proven to be reliable and valid in 
many healthy and clinical populations, no questionnaire to this date has been validated 
specifically within an OSA population (Bamberga et al., 2015; Batool Anwar et al., 2014; 
Jean et al., 2017; and West et al., 2009). The lack of a validated questionnaire makes it 
difficult to know whether physical activity levels of OSA patients can be accurately 
assessed through questionnaires. 
There are many possibilities as to why validated questionnaires in other 
populations may not be valid within the OSA population, perhaps the most significant 
being the presence of daytime sleepiness which is directly related to a lack of 
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concentration (Zhu et al., 2007). Daytime sleepiness and decreased ability to concentrate 
may impede OSA patient’s ability to answer physical activity questionnaires which 
commonly rely on their memory from over the course of a week. Some OSA patients, 
particularly those who are overweight, tend to be sedentary and may have difficulties 
interpreting questionnaires which ask specific questions about exercise and activity 
intensities (Igelstrom et al., 2013). Considering these factors, it should not be assumed 
that a previously validated questionnaire will be valid within the OSA population. This 
issue can be seen in previous research which has relied on previously validated 
questionnaires to measure activity levels within the OSA population and produced 
conflicting results (Basta et al., 2008; Batoll-Anwar et al., 2014; Bamberga et al., 2015; 
Theorell-Haglow et al., 2011). Considering these facts, the current work aims to 
determine if there is a questionnaire(s) that can be used as a valid instrument to measure 
physical activity within the OSA population.  
There are two physical activity questionnaires that hold promise in being utilized 
within the OSA population. The first is a well-established questionnaire called the 
International Physical Activity Questionnaire Short Form (IPAQ-SF) which can be found 
in appendix 4 (Marshall et al., 2003). The second is a newer questionnaire in comparison 
to the IPAQ-SF, called the Physical Activity Vital Sign (PAVS) which can be found in 
appendix 5 (Ball et al., 2012). The reason the IPAQ-SF and PAVS are promising is 
because they are both concise and contain questions which are common across the 
general population (Pereira et al., 1997). These facts are important when considering 
questionnaires that can be implemented into clinical settings where there is a vast array of 
patients and limited time.   
6 
Significance  
Obstructive sleep apnea is a serious health disorder which is becoming more 
prevalent throughout the population. Currently, a large portion of the OSA population is 
overweight or obese (Peppared et al., 2013). While being overweight is a primary cause 
of OSA, OSA may contribute to increases in body weight due to sedentary behavior 
(Igelstrom et al., 2013). This is a concerning fact because both OSA and excess body 
weight result in many of the same metabolic and cardiovascular disorders. Equally 
troubling is that CPAP, the most popular and effective treatment for OSA, has not shown 
to decrease body weight and may in fact cause it to increase (Drager et al., 2015).  
Increasing physical activity levels is a known method for maintaining or reducing 
body weight and has also been shown to be effective in reducing the severity of OSA, 
even when body weight reduction is not realized (Sengul et al., 2011; Ueno et al., 2011, 
Kline et al., 2009). These facts make gauging physical activity levels in all patients with 
OSA, and especially in those who are overweight or using CPAP, a necessity because 
having a validated physical activity questionnaire would provide a quick and inexpensive 
tool for clinicians to accurately determine the amount and patterns of physical activity. It 
would also allow clinicians to determine how to proceed with appropriate protocols for 
treatment. Lastly, it could serve as a measure for both physicians and researchers to 
determine if future protocols aimed at increasing physical activity levels of OSA patients 
are effective.   
Specific Aim 1: To assess the criterion validity of the IPAQ-SF, PAVS, and logbook 
within an OSA population by comparing their results with an objective measure of 
accelerometry over the course of one week. 
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Hypothesis 1. IPAQ-SF, PAVS, and logbook will correlate strongly with one 
week of accelerometry data from individuals with OSA.  
Specific Aim 2: To determine reliability of the IPAQ-SF and PAVS within an OSA 
population through a test retest design.  
Hypothesis 2. IPAQ-SF and PAVS will show strong reliability when taken 
two times separated by at least one week. 
Specific Aim 3: To determine construct validity of the IPAQ-SF, PAVS, and logbook 
within an OSA population by comparing the results of the questionnaires with BMI, 
sleepiness, OSA disease severity, CPAP adherence, sedentary time, and quality of life.  
Hypothesis 3. Individuals with OSA that have lower levels of physical activity 
as indicated by the IPAQ-SF and PAVS will have a higher BMI, disease 
severity, and sleepiness while having a lower sleep quality and CPAP 
adherence. 
Specific Aim 4: To determine the relationship between objective physical activity levels 
and BMI, sleepiness, OSA disease severity, CPAP adherence, and quality of life. 
Hypothesis 4. Individuals with OSA that have lower levels of physical activity as 
indicated by accelerometry will have a higher BMI, disease severity, and 
sleepiness while having a lower sleep quality and CPAP adherence. 
Methodology  
The study design allowed for investigation of the criterion validity, construct 
validity, and reliability of the IPAQ-SF and PAVS within the OSA population. The study 
used a descriptive correlation research design. The study consisted of 40 OSA patients 
between the ages of 18-65 who had been diagnosed with moderate-severe OSA. 
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Participants were recruited from within central Indiana through word of mouth, flyers, 
email, and the assistance of Indiana Clinical and Translational Sciences Institute (CTSI). 
The flyer, email, and CTSI assistance can be found in appendices 1, 2, and 3, 
respectively. Upon enrollment, participants completed the IPAQ-SF and PAVS 
questionnaires, and then wore a hip worn accelerometer for seven days for the assessment 
of physical activity levels. After the seven days were completed, each participant 
completed the questionnaires again. The study took place over the course of six months 
which allowed for different beginning dates based on recruitment.  
 Reliability of the IPAQ-SF and PAVS was determined in a test retest design 
wherein OSA patients took the questionnaires two separate times at least seven days 
apart. The results of the two questionnaires were compared to assess whether there was 
agreement through quantitative analysis. Determining reliability of the IPAQ-SF and 
PAVS was important because if the results of the questionnaires were not repeatable in 
the OSA population then they cannot be valid. 
Construct validity of the IPAQ-SF and PAVS was assessed through quantitative 
analysis by examining the consistency between the results of the questionnaires with 
factors related to OSA, such as BMI, disease severity, CPAP adherence, sleepiness, 
quality of life, and cognitive impairment. Questionnaires for sleepiness, quality of life, 
and cognitive impairment can be found in appendices 6, 7, and 8, respectively. 
Establishing construct validity of the IPAQ-SF and PAVS within the OSA population 
was important because it helped determine if the questionnaires were accurate in their 
overall assessment of an OSA patient.   
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Criterion validity was assessed through quantitative analysis by comparing the 
results of the IPAQ-SF and PAVS with the objective measure of accelerometry. 
Determining the criterion validity of the questionnaires within the OSA population was 
important because if the questionnaires did not measure what they were intended to then 
they would serve no value. 
Delimitations  
The study’s delimitations include:  
1. A power analysis was completed in order to ensure the probability of not 
committing a Type II statistical error or accepting the null hypothesis when it is in 
fact false. 
2. In order to study a sample of OSA patients who are between the ages of 18-65 and 
have moderate to severe OSA, participant’s electronic medical records were 
assessed.    
3. Participants data from their electronic medical records were collected one week 
prior to the first visit. 
4. The physical activity questionnaires were completed at two time points which 
were 7 days apart. 
5. Questionnaires were completed in person using pencil and paper. The 
questionnaires were completed privately by the participants. 
6. In order to collect 7 days of objective physical activity data, participants wore a 
hip worn accelerometer for 7 consecutive days.  
7. The two questionnaires were put into packets randomly to reduce the potential of 
survey fatigue. 
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Assumptions   
The study’s assumptions include: 
1. Participants voluntarily chose to participate in this study out of interest due to the 
nature of research being conducted.  
2. Participants answered the questionnaires truthfully, accurately and to their best 
ability during each of the two data collection time points.  
3. Participants were able to interpret and comprehend what the questionnaires were 
asking of them.  
4. Participants wore the accelerometers truthfully and did not exaggerate sleeping 
time.  
5. The accelerometers accurately measured physical activity levels. 
6. Participants did not increase physical activity levels due to the fact they were in a 
research study studying physical activity levels. 
Limitations 
The study’s limitations include: 
1. Due to circumstance, the study was limited to participants who reside in central 
Indiana. Geographical and cultural differences that exist in other states and 
countries may influence the results differently. 
2. Accelerometers are not 100% accurate in determining physical activity levels. 
3. Participants may answer the questionnaires dishonestly to avoid embarrassment or 
please the researcher.  
4. A shortage of empirical data to support the study’s hypotheses did not allow for 
comparison of results to previous studies.  
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5. OSA patients tend to have many and varying comorbidities which are challenging 
to account for and may have affected physical activity levels and questionnaire 
answers.  
6. While many questionnaires exist, the study only examined two due to time and 
the setting of a doctor’s office.     
Definition of Terms 
1. Obstructive sleep apnea (OSA): is a sleep condition which involves the 
partial or complete blockage of the upper airway during sleep (Eckert 
& Malhotra, 2008) 
 
2. Physical Activity: bodily movement produced by the contraction of 
skeletal muscle that significantly raises energy expenditure above 
basal metabolic level. (American College of Sports Medicine, 2013) 
 
3. Exercise: a type of physical activity consisting of planned, structured, 
and repetitive bodily movement done to improve or maintain one or 
more components of physical fitness. (American College of Sports 
Medicine, 2013) 
 
4. Questionnaire: a set of questions or other prompts used to obtain 
information from a respondent about a topic of interest (American 
Psychological Association, 2015)  
 
5. Reliability: the trustworthiness or consistency of a measure, that is, the 
degree to which a test or other measurement instrument is free of 
random error, yielding the same results across multiple applications to 
the same sample. (American Psychological Association, 2015)   
 
6. Validity: the degree to which empirical evidence and theoretical 
rationales support the adequacy and appropriateness of conclusions 
drawn from some form of assessment. (American Psychological 
Association, 2015) 
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Chapter 2: Review of Literature 
Introduction  
Obstructive sleep apnea (OSA) is a sleep condition which involves the partial or 
complete blockage of the upper airway during sleep (Eckert & Malhotra, 2008). A partial 
blockage results in shallow breathing (hypopnea) while a complete blockage results in 
total cessation of breathing (apnea) (Eckert & Malhotra, 2008). In either case, decreases 
in oxygen saturation (hypoxia) occur which typically cause arousal from sleep. The 
severity of OSA is determined by the number of hypoxic episodes per hour, with one 
episode classified as either apnea lasting 10 seconds and a 3% reduction in oxygen 
saturation or hypopnea which decreases airflow by 50% and lasts 10 second with a 3% 
reduction in oxygen saturation (Eckert & Malhotra, 2008). The number of episodes per 
hour is used to determine the apnea hypopnea index (AHI), with more frequent episodes 
indicating more severe OSA (Normal: AHI <5, Mild: AHI 5≤ but <15, Moderate: AHI 
15≤ but <30, Severe: AHI ≥30). In order for the sleep apnea to be defined as obstructive, 
thoracoabdominal effort must be present in at least 70 percent of episodes.  
Over time, if OSA is left untreated, the severity of OSA typically increases 
resulting in deleterious effects on health (Dick et al., 2007; Hoffman et al., 2002; Zhu et 
al. (2007); Peppard et al., 2000). Moderate and severe OSA have numerous negative 
health effects on the human body including hypertension, insulin resistance, 
cardiovascular disease, and neurological dysfunction (Dick et al., 2007; Hoffman et al., 
2002; Zhu et al. (2007); Peppard et al., 2000). Research has found a direct relationship 
between excess body weight and OSA and has also demonstrated that the severity of 
OSA increases with increases in body weight (Peppard et al., 2000). The relationship 
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between OSA and body weight remains complex as excess body weight is a risk factor 
for many of the same cardiovascular and metabolic diseases as OSA.  
Considering the problematic and complex relationship between OSA and excess 
body weight as well as the fact that CPAP does not result in body weight reductions, 
recommendations for increasing exercise and physical activity in OSA patients, 
especially those who are overweight and or receiving CPAP, may be a viable means to 
increase daily energy expenditure. Increases in daily energy expenditure would likely 
assist in reducing the severity of OSA through a combination of poorly understood 
physiological factors and body weight reductions, both of which would ultimately reduce 
the risk of developing or worsening metabolic and cardiovascular diseases.  
These facts make gauging physical activity levels of those with OSA important. A 
validated questionnaire would provide patients with a clear picture of their activity levels 
which may be beneficial in motivating the patients to increase activity levels. It would 
also be beneficial to clinicians in determining if physical activity recommendations 
should be made as part of treatment for OSA. Lastly, it could also serve as a measure for 
both physicians and researchers to determine if future protocols aimed at increasing 
physical activity levels of OSA patients are effective.   
Presently, when physical activity levels are gauged in a clinical setting, 
questionnaires are typically used, however, no questionnaire to this date has been 
validated in the OSA population resulting in potentially inaccurate assessment of physical 
activity levels for this population. This review will present the exiting literature on the 
etiology, pathophysiology, and related sequelae of OSA. This review will also summarize 
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the effects of exercise on OSA and lastly describe existing physical activity 
questionnaires which may be appropriate for use in the OSA population.   
Etiology of OSA  
Age. Research has shown that with increasing age comes greater difficulty with 
falling asleep and staying asleep. A study by Foley and colleagues (1995) found that over 
50% of individuals older than 65 had sleep related complaints. The prevalence of OSA 
has been shown to increase with age in both men and women. A study by Bixler and 
colleagues (1998) found the presence of OSA to be 3.2% for men between the ages of 20-
44 years of age and 18.1% for those between the ages of 61-100 years of age. A later 
study by Bixler and colleagues (2001) found the presence of OSA in women to be 0.6% 
for those between the ages of 20-44 years of age and 7.0% for those between the age of 
61-100 years of age. Some theories as to why OSA prevalence increases with age are 
increased fat within the area of the pharynx, anatomical changes to structures located 
around the pharynx, and lengthening of the soft palate (Malhotra et al., 2006). 
Body Weight. Excess body weight has been shown to be the strongest risk factor 
for OSA with over 60% of patients referred for sleep tests being overweight (Strohl & 
Redline, 1996). Numerous studies have concluded that there is a direct relationship 
between excess body weight and OSA (Bixler et al., 1998; Bixler et al., 2001). Not only 
has a relationship between excess body weight and OSA been shown, but an increase in 
weight over time has been shown to accelerate the severity of OSA (Newman et al., 
2005). To further solidify the relationship between excess body weight and OSA, a study 
by Grunstein and colleagues (2007) found that a reduction in excess body weight in those 
with OSA resulted in either a decrease in the severity of OSA or complete attenuation of 
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the disease. Excess body weight is believed to influence OSA through several different 
mechanisms, including increased fat deposits around the pharynx which narrow the upper 
airway, decreased airway patency due to altered neural compensatory mechanisms, 
respiratory instability, and reduced functional residual capacity (Fogel et al., 2004). 
Sex. Many studies have confirmed that there is a higher prevalence of OSA in 
males versus females. The epidemiological studies which have examined OSA in males 
and females have found between a 2 to 3:1 ratio in favor of males (Bixler et al., 2001; 
Duran et al., 2001). Besides a greater prevalence of OSA in men than women, 
polysomnography tests have shown women have less frequent arousals with shorter 
durations when sleeping, collectively resulting in less severe hypoxia (Ware et al., 2000). 
Theories as to why differences in OSA exist between men and women are anatomical 
differences of the upper airway and hormonal differences. The effects of hormones on 
OSA are best seen in a study by Bixler and colleagues (2001) which found that the 
prevalence of OSA was higher in post-menopausal women. In the same study by Bixler 
et al., (2001) it was found that post-menopausal women on hormone replacement therapy 
were less likely to have OSA. 
Race. Studies examining OSA in eastern cultures have found that the prevalence of 
OSA in Asians is similar to that of North Americans and Europeans. These findings were 
particularly surprising because despite a lower prevalence of obesity in the east, OSA 
prevalence was the same (Li et al., 2000). In a follow-up study by Lam and colleagues 
(2005), who examined the differences between facial anatomy of those in the east and 
west, it was concluded that differences in facial anatomy are the likely cause of the equal 
prevalence of OSA in Asians despite significantly lower obesity rates.     
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Studies examining African Americans have found that those less than 25 years old 
and those 65 years old and older have a higher prevalence of OSA than other racial 
groups (Redline et al., 1997). Studies examining Hispanics have found that they are more 
likely to snore with OSA than other racial groups (O’Connor et al., 1997). The reasoning 
behind these differences seen in African Americans and Hispanics is poorly understood, 
but it is possible, particularly in those equal to or older than 65, that the existence of 
comorbid conditions commonly seen in minority groups contributes to the increased 
prevalence of OSA (Douglas et al., 2003; Cossrow and Falkner, 2004). More research is 
needed in understanding health disparities within OSA minority groups.  
Facial Anatomy. Differences in facial anatomy have been observed in those with and 
without OSA which likely influence its development (Lee et al., 2010). The enlargement 
of the tonsils, tongue, and soft palate, inferiorly located hyoid bone, mandibular and 
maxillary retroposition, and decreased posterior airway space have all been indicated as 
anatomical possibilities for the development of OSA. The length of mandible has been 
shown to have the strongest association with OSA (Lee et al., 2010).  
Genetics. In the previous sections, the factors of obesity, race, and facial anatomy 
were implicated as underlying etiology for OSA. With this in mind, there may be an 
existing genetic component which is influential in the development of OSA. Numerous 
studies have indicated this possibility. In a study by Redline and colleagues (1995) it was 
found that those with first-degree relatives who have OSA were more at risk of 
developing OSA when compared with those whose first-degree relatives did not have 
OSA. The study also found that those with a greater number of relatives with OSA had an 
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increased risk of developing OSA. The Cleveland family study found that the severity of 
OSA was directly linked to genetic factors (Redline and Tishler, 2010). 
Rostral Fluid Shift. The prevalence of OSA has been demonstrated to be higher in 
patients who have fluid retention, such as patients with heart failure. Due to gravity, it is 
believed that fluid accumulates in the intravascular and interstitial spaces of the legs 
throughout the day. Once these patients lay down at night, the fluid redistributes rostrally 
and ends up in the neck and causes increased pressure and narrowing of the upper 
airways (White and Bradley, 2013).        
Pathophysiology of OSA  
Carotid Chemoreceptor sensitivity. Activation of the sympathetic nervous 
system is elevated in OSA patients when they are both sleeping and awake. This increase 
in sympathetic activation during sleep is likely due to the chronic intermittent hypoxia 
(CIH) experienced from OSA (Dick et al., 2007). The CIH during sleep results in 
activation of the carotid body chemoreceptors via decreases is oxyhemoglobin which 
results in sympathetic activation (Dick et al., 2007). Aside from sleep, sympathetic 
activity has also been shown to be elevated in OSA patients during wakefulness which is 
evidenced by increased discharge rates of carotid chemoreceptors in OSA patients even 
during normoxia (Peng et al., 2003). The enhanced sympathetic activity during 
wakefulness indicates that the CIH experienced from OSA sensitizes the carotid 
chemoreceptors and results in enhanced sympathetic activity while awake and asleep 
(Dick et al., 2007).  Research has pointed to the development of reactive oxygen species 
from CIH as a potential cause of sensitized carotid chemoreceptors in OSA patients (Dick 
et al., 2007).  
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Enhanced sympathetic activity is the likely driver of elevated angiotensin (ANG) 
II seen in OSA patients. Chronic intermittent hypoxia has been shown to upregulate 
angiotensin II receptors in the carotid body and lead to enhanced carotid body activity 
resulting in an elevated sympathetic state (Li et al., 2006). ANG II has also been shown 
to activate NADPH oxidase which drives the production of reaction oxygen species 
within cells. These reactive oxygen species have also been demonstrated to cause the 
sensitization of the carotid chemoreceptors (Li et al., 2007). In conclusion, ANG II likely 
sensitizes the carotid chemoreceptors through due to upregulation of angiotensin II 
receptors from CIH. Angiotensin II may also sensitize the carotid body chemoreceptors 
through activating NADPH oxidase which results in oxidative stress to the 
chemoreceptors  (Li et al., 2006; Li et al., 2007).  
Decreased Baroreflex Control. Research has indicated that OSA patients have 
decreased baroreflex control when compared to healthy patients. (Carlson et al., 1996). 
This is important when considering OSA patients have elevated sympathetic activity due 
to sensitized carotid chemoreceptors which results in elevated blood pressure. A 
desensitized baroreflex results in an inability to activate the parasympathetic nervous 
system and consequently further exacerbates the effects of an already elevated 
sympathetic nervous system (Carlson et al., 1996). 
Research has indicated that carotid chemoreceptors becoming sensitized most 
likely comes prior to the desensitized baroreceptors. In a study examining CIH in rats, 
arterial blood pressure increased prior to the baroreceptors becoming desensitized (Li et 
al., 2006). If this holds true in humans is not fully understood, but nonetheless, a 
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combination of sensitized carotid chemoreceptors and desensitized baroreceptors results 
in a hyperactive sympathetic environment.    
Central Sympathetic. Nitric oxide (NO) is an inhibitor of carotid body 
chemosensitivity as demonstrated by research in rabbits which has shown inhibition of 
NO results in increased carotid chemoreceptor sensitivity (Sun et al., 1999). Research in 
rats has demonstrated that CIH results in downregulation of NO in carotid 
chemoreceptors most likely due to increased ANG II which has a strong inhibitory effect 
on NO (Marcus et al., 2010). In conclusion, downregulation of NO from CIH may be 
responsible for increases in carotid chemoreceptor sensitivity.  
CIH has been suggested to increase central sympathetic output by way of ANG II. 
Sympathetic neurons in the brain stem receive input from higher centers such as the 
paraventricular nucleus (PVN) of the hypothalamus (Dampney et al., 2005). ANG II is a 
known inhibitor of NO in the central nervous system where it serves to regulate central 
sympathetic outflow (Liu et al., 1998). CIH exposure decreases NO expression in the 
PVN and increases angiotensin receptor expression indicating CIH may increase central 
sympathetic output (Liu et al., 1998). Consequently, hypoxia in OSA patients may 
increase ANG II and decrease NO which may lead to the increased sympathetic state 
commonly seen in OSA patients.    
Sympathetic State and Insulin Sensitivity. It is well established that OSA 
patients have elevated levels of catecholamines (Minemura et al., 1998). These elevated 
levels of catecholamines in OSA patients may have an influence over insulin resistance. 
Besides countering the action of insulin, catecholamines also inhibit the release of insulin 
from the pancreases (Hoffman et al., 2002). Growth hormone has been demonstrated to 
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be reduced in OSA patients, which may also play a role in insulin resistance because a 
lack of growth hormone results in a decrease of insulin-like growth factor I (IGF-I), 
which has insulin-sensitizing actions (Gianotti et al., 2002). 
Evidence for OSA and insulin resistance has also been demonstrated in rats. In a 
study examining rats who were exposed to CIH, sensitization of the hypothalamic-
pituitary-adrenal (HPA) axis was observed, and consequently levels of corticosterone 
were elevated. Importantly, elevated levels of corticosterone was positively correlated 
with levels of blood sugar signaling a potential driver of insulin resistance (Ma et al., 
2008).  
Inflammation and Insulin Sensitivity.  In obese subjects, numerous factors have 
been suggested to create a pro-inflammatory environment, including the production of 
reactive oxygen species and inflammatory cytokines (Yuan et al., 2001). Both reactive 
oxygen species and inflammatory cytokines have shown associations with insulin 
resistance. These same pathways which induce inflammation have been demonstrated to 
become active under CIH seen in OSA patients (Dyugovskaya et al., 2002).  Intuitively, 
consistent states of hypoxia have the potential to drive the generation of reactive oxygen 
species within cells, and as discussed in previous sections, the ANG II NADPH oxidase 
pathway seen in OSA patients is also involved in their production.  
Chronic Intermittent hypoxia may also drive the production of pro-inflammatory 
cytokines which have been directly implicated in insulin resistance. Two important 
inflammatory cytokines known to be involved with insulin resistance in obese patients 
are tumor necrosis factor alpha (TNF-α) and interleukin 6 (IL-6). Both TNF-α and IL-6 
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have been shown to increase from CIH (Minoguchi et al., 2004). See figure 1 for a 
depiction of the sleep apnea insulin resistance pathway.  
Figure 1. Sleep Apnea Pathophysiology  
 
Neural Injury. It is well established that OSA leads to cognitive impairments. 
Studies in mice have shown that CIH results in irreversible decreases in sleep latency and 
reductions in total wake time (Veasey et al., 2004). Similar to the effects seen in humans, 
Zhu and colleagues (2007) have shown that the neurons involved in wakefulness are 
injured by CIH. The injured neurons observed in the study by Zhu et al. (2007) were 
catecholaminergic and showed increased oxidative injury in response to the CIH. The 
increased oxidative injury is likely caused by NADPH oxidase which is found within the 
neurons. Thus, the elevated sympathetic state in OSA may play an important role in 
damaging wake neurons by inducing oxidative stress.   
Svanborg (2005) demonstrated through electromyography that OSA patients have 
impaired sensory and motor nerve function of the palatopharyngeus muscle. This finding 
is supported by the fact treatment of OSA partially reverses the deficits seen in the motor 
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and sensory nerves (Svanborg, 2005). Histological studies have shown motor neurons of 
the palatopharyngeus muscle to be demyelinated in OSA patients (Boyd et al., 2004). The 
severity of peripheral nerve dysfunction correlates with oxyhemoglobin desaturations in 
sleep apnea.  
Sequalae of OSA 
Hypertension. Many studies have identified associations and direct relationships 
between hypertension and OSA (Peppard et al., 2000). In the Wisconsin Sleep Study, 
there was a linear relationship between OSA severity and hypertension (Peppard et al., 
2000). Animal studies have demonstrated exposure to intermittent hypoxia produces 
elevations in blood pressure during both the period of exposure and afterwards in 
normoxic conditions (Brooks et al., 1997). Other evidence pointing towards a relationship 
between OSA and hypertension is seen in CPAP studies. Studies examining CPAP use in 
OSA patients have shown reductions in daytime blood pressure and in 24-h mean blood 
pressure (Becker et al., 2003).  
Stroke  
Stroke. An association between OSA and stroke has been observed in numerous 
studies (Arzt et al., 2005; Wessendorf et al., 2000). Arzt and colleagues (2005) found that 
moderate to severe OSA was associated with increased risk of stroke, compared to mild 
OSA which did not increase stroke risk. Munoz and colleagues (2006) found that stroke 
was three times more likely in subjects with AHI values greater than 30 compared to 
those with values less than 30. The study also found that patients with coronary artery 
disease and OSA (AHI >10) were more likely to have a stroke when compared to those 
without OSA (Munoz et al., 2006). A large clinical study examined the effects of OSA on 
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all-cause mortality in patients with preexisting stroke and found that those with OSA 
hypoxia hypopnea index values of greater than 30 were at a higher risk of death from any 
cause than in those with values below 15 (Sahlin et al., 2008).   
Coronary Artery Disease. Numerous studies have shown relationships between 
OSA and coronary artery disease (Mooe et al., 1996; Sorajja et al., 2008). These studies 
found OSA to be of equal significance to diabetes, hypertension, and obesity when 
predicting the likeness of coronary artery disease. When coronary artery calcification was 
determined by computed tomography, a positive relationship was found between OSA 
severity and level of calcification (Sorajja et al., 2008). It is also possible that OSA may 
influence morbidity and mortality in patients with existing coronary disease. Since OSA 
often causes chest pains and ischemia, OSA may increase the incidence of heart attacks 
in those with existing coronary artery disease.  
Diabetes. The Nurses' Health Study followed 69,852 women without diagnosed 
diabetes finding 1,957 developed diabetes over a 10 year period. The study found that 
those who snored were two times more likely to develop diabetes than those who did not 
(Al-Delaimy et al., 2002). Other studies have used polysomnography to measure OSA 
more objectively and have found the presence of severe OSA to be positively associated 
with diabetes as determined by fasting insulin and glucose (Lp et al., 2002). These studies 
came to their conclusions independent of obesity. Similar findings were seen in a study 
by Punjabi et al. (2002) who analyzed subjects with mild to moderate OSA and found 
increased fasting and 2-h glucose levels as determined glucose tolerance tests. One of the 
largest studies to examine OSA and obesity by Punjabi et al. (2004) directly assessed 
2,656 subjects from the ongoing Sleep-Heart-Health study. They found that subjects with 
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AHI values of 15 or greater had increased insulin resistance values as determined by The 
Homeostasis Model Assessment. They also found elevated fasting glucose levels and 
elevated two hour glucose levels, as determined by glucose tolerance tests. The findings 
of this study were still significant after adjustment for age, BMI, waist girth, race, sex, 
and smoking.  
Daytime sleepiness. Two-thirds of adults with OSA complain of significant 
sleepiness and fatigue (Chervin et al., 2002). The value which has been shown to most 
strongly predict sleepiness from OSA is the desaturation index (Bedard et al., 1993). 
While treatment of OSA with CPAP has shown improvement in subjective sleepiness, 
clinical trials have found that when sleepiness is examined objectively through sleep 
latency there is no significant improvement from CPAP treatment. These studies have 
found less than a 1-minute improvement in sleep latency from CPAP treatment (Patel et 
al., 2003).  
Cognitive Performance. OSA has been shown to impair cognitive function. As 
an example, Thomas and colleagues (2005) examined OSA patients’ cognitive function 
via functional MRI in 21 to 50-year old subjects. The OSA patients had less activation of 
the prefrontal cortex while performing a working memory task. A similar observation 
was made in hypoxic and nonhypoxic subjects with sleep apnea, suggesting that hypoxia 
does not influence the decrement in prefrontal cortical activation during learning. In 
contrast, hypoxic subjects showed far less activation in the parietal cortex. This suggests 
that within the brain there are regional differences for hypoxia-sensitive neural tissue and 
arousal or sleep disruption-sensitive neuronal tissue.  
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One of the more alarming findings from recent studies is that young children with 
sleep apnea may also have neuronal loss and cognitive impairments. Halbower et al. 
(2006) examined 19 children with sleep apnea and 12 controls, matched for age, gender, 
ethnicity, and socioeconomic class. Children with severe sleep apnea had significant 
decrements in their IQ (15 points) and significant decrements in verbal working memory 
and verbal fluency.  
Challenges to Diagnosis and Treatment  
 Diagnosis. Presently some research estimates that over 85% of patients with 
moderate to severe OSA are undiagnosed (Kato et al., 2009). One of the most important 
issues surrounding this is believed to be that patients with OSA are unaware of the 
snoring and repetitive episodes of arousal during the night (Victor, 1999). If left unware 
of these issues, OSA will commonly present itself to both the patients and clinician as 
unrelated health disorders. This is due to the fact OSA has many comorbidities and 
sequelae, as previously discussed, which can present similar symptoms. 
 Even when OSA is suspected, diagnostic issues persist. Polysomnography is a 
multiparametric test which is run during a night of sleep. The test examines brain, eye, 
muscle, and heart activity along with respiratory effort and arterial oxygen saturation. 
While polysomnography lab tests are effective in diagnosing OSA, they are not widely 
available and typically cost thousands of dollars. While insurance companies will 
typically cover the cost of a sleep study, the United States Census Bureau estimates that 
there are currently 28.1 million uninsured Americans and that number is estimated to rise 
in the coming years (USCB, 2018). This is particularly troubling for OSA in that minority 
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groups such as Hispanics and African Americans are more often uninsured and have 
higher rates of OSA than whites (Redline et al., 1997; O’Connor et al., 1997.).  
Treatment. When OSA is diagnosed, the standard of care for the great majority of 
patients is CPAP. When used effectively, CPAP has been shown to improve daytime 
drowsiness, physical functioning, vitality, mood, and attenuate OSA-related hypertension, 
an important cardiovascular disease (CVD) risk factor (Bazzano et al., 2007; Fatureto-
Borges et al., 2016; Liu et al., 2016; Lewis et al., 2017; Zaho et al., 2017). Unfortunately, 
adherence rates remain unacceptably low, ranging between 17% and 85% (Sin et al., 2002; 
Weaver & Grunstein, 2008; Wolkove et al., 2008; Wozinak et al., 2014).  Even in patients 
reporting “good adherence”, CPAP has not been shown to promote weight loss and may 
even cause weight gain (Drager et al., 2015).  
Weight Gain and Health 
 
CPAP and Weight Gain. A meta-analysis by Drager and colleagues (2015) 
looked at the influence of CPAP on body weight in those with OSA. They identified 25 
separate studies which used CPAP versus controls for a minimum treatment duration of 4 
weeks. These studies included a total of 3,181 patients, most of whom were overweight 
or obese. The analysis concluded that CPAP use results in significant increases in body 
weight with no single predictor for the cause. This is problematic due to the fact excess 
body weight causes OSA and increases in body weight increase the severity of OSA 
while driving many of the same metabolic disorders which OSA causes such as 
hypertension, heart disease, and diabetes.  
Hypertension. Hypertension has been linked to excess body weight in many 
studies (Black, 2003). Hypertension occurs when blood vessels have an increased 
27 
resistance to blood flow (Black, 2003). Elevated blood pressure naturally occurs during 
times of arousal to move larger quantities of blood to desired organs, however, during a 
resting state, blood pressure should not be elevated as seen in a large majority of the 
obese population (Bassett, 2008). Many cardiovascular complications have been shown 
to arise from hypertension such as left ventricular hypertrophy, atrial and ventricular 
arrhythmias, diastolic heart failure, systolic heart failure, and most commonly ischemic 
heart disease with or without congestive heart failure. (Black 2003). 
 Possible mechanism underlying the development of hypertension in obese 
individuals are altered angiotensin II and aldosterone secretion (Zorad, 1995). Obesity 
has also been shown to cause structural changes to the kidneys which interfere with and 
eventually cause the total loss of nephron function resulting in hypertension (Hall 2003). 
Ectopic fat deposits on the kidneys measured by CT have also been shown to be 
predictive of hypertension (Tchernof and Després, 2013). Consequently, while OSA may 
cause hypertension, weight gain from OSA may exacerbate the issue by increasing 
angiotensin II and aldosterone secretion.   
Atherosclerosis. Ischemic heart disease or atherosclerosis arises from the 
dyslipidemic state frequently observed in obese individuals (Tchernof and Després, 
1996). Atherosclerosis occurs when an artery wall thickens due to the accumulation of 
atheromas, which form due to the invasion of triglycerides, cholesterol, and white blood 
cells (Lang et al. 2011). The development of atherosclerosis can be influenced by a 
variety of factors such as obesity, genetics, dietary choices, and the environment (Lang et 
al. 2011). While there are many possibilities and theories for how these factors initiate 
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atherosclerotic development, most scientific literature points towards being overweight 
and or obese, as one of the primary driving factors (Tchernof and Després, 2013).  
Over time continued development of atheromas lead to stenosis or narrowing of 
the lumen (Austin, 1988). The normally thin tunica intima becomes the thickest layer of 
the vessel with large lighter colored atheroma’s within. This narrowing leads to increased 
pressure within the arteries and eventual ruptures of atheroma’s. A rupture of an 
atheroma causes blood clotting and obstruction of blood flow which typically results in a 
myocardial infarction or heart attack (Austin, 1988). If the heart attack is not fatal the 
rupture is then covered by a fibrous organization which results in greater stenosis. The 
increased stenosis further increases pressure within the arteries which increases the 
chance of another atheroma rupture and consequent heart attack (Pascot et al., 2001). 
Consequently, while OSA may cause heart disease, weight gain from OSA may 
exacerbate the issue by increasing the development of atheromas within coronary arteries.    
Type 2 Diabetes Lots of evidence exists for the association between excess body 
weight and insulin resistance which ultimately leads to the development of type II 
diabetes (Karter, 2005). Insulin resistance occurs when insulin can longer bind to its 
tyrosine kinase receptor, consequently resulting in a lack of glucose transporter 4 
(GLUT4) translocation to the cell membrane which is what normally allows glucose into 
the cell (Karter, 2005). This results in abnormally high levels of not only glucose, but 
also insulin, which over time can lead to kidney failure, acidosis, and death if not treated 
(Karter, 2005).    
Excess body weight may contribute to the development of diabetes through the 
release of cytokines such as TNF-α and IL-6 by adipocytes. The release of these 
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cytokines results in a systemic inflammatory state, disrupting insulin receptor function, 
causing insulin resistance (Tchernof and Després, 2013). Excess body weight has also 
been shown to be strongly associated with elevated levels of free fatty acids in 
circulation. This likely occurs under the influence of inflammatory cytokines which have 
been shown to be elevated in overweight individuals, as discussed prior (Tchernof and 
Després, 2013). The overexposure of free fatty acids may impair liver metabolism 
leading to the overproduction of apolipoprotein B-containing lipoproteins, increased 
hepatic glucose production, and reduced hepatic degradation of insulin, which 
exacerbates systemic hyperinsulinemia (Tchernof and Després, 2013). Consequently, 
while OSA may cause diabetes weight gain from OSA may exacerbate the issue by 
increasing the release of TNF-α and IL-6 by adipocytes. 
Exercise, Body Weight, and OSA 
 Exercise.  Increased physical activity levels have long been known to decrease 
excess body weight and reduce or attenuate related metabolic disorders such as 
hypertension, diabetes, and atherosclerosis. Considering the strong and complicated 
relationship between OSA, obesity, and the metabolic disorders which are commonly 
seen in both, increased physical activity levels in OSA patients may have the potential to 
provide many benefits. The existing research on the effects of exercise in OSA patients 
has proven promising.   
Epidemiological Studies. Some initial compelling evidence for the study of 
nutritional and physical activity interventions in OSA patients was seen in a large 
longitudinal study by Peppard et al. (2000) in which 690 Wisconsin residents were 
evaluated twice over 4 years for disordered breathing. The study found that those who 
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increased their weight by 10% over the course of 4 years significantly increased the 
number of apnea hypopnea events per night. Importantly, the study also found that those 
who decreased their weight by 10% significantly decreased the number of apnea 
hypopnea events per night. The reasons for the weight varied among participants but 
included bariatric surgery, exercise, and diet. The evidence from this study clearly 
demonstrates a relationship between weight gain and an increased risk for the 
development and severity of OSA, while weight loss is related to a reduced severity of 
OSA. 
Another large longitudinal epidemiological study supporting the importance of 
weight and OSA was by Newman and colleagues (2005) which was designed to examine 
the impact of disordered breathing on cardiovascular disease risk. The study analyzed 
2968 men and women via polysomnography over the course of 5 years. The study found 
that increased weight over time increased the risk of disordered breathing development 
and severity and that decreased weight over time decreased the severity of disordered 
breathing. 
Experimental Studies. One of the earliest studies to directly focus on employing 
physical exercise interventions as a modality for improving OSA was by Giebelhaus et al. 
(2000), in which 11 adult participants with moderate to severe OSA were recruited. All 
participants completed two hours of exercise twice per week for 6 months, with one 
session being aerobic exercise and the other being resistance training. Before and after 
the 6-month intervention, polysomnography was utilized to determine sleep quality. 
Following the study, a significant decrease in the number of apnea hypopnea episodes 
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were seen (32.8 to 23.6). Interestingly, despite an improvement in objective sleep quality, 
no decreases in body weight were found.    
 A study by Ueno and colleagues (2009) recruited 17 severe sleep apnea patients 
with heart failure. Of the participants, eight had obstructive sleep apnea (OSA) and nine 
had central sleep apnea (CSA). All participants completed a 4-month exercise program 
which consisted of 60 minutes of aerobic exercise three times per week. Before and after 
the 4-month period, polysomnography was used to determine the severity of OSA. The 
study found exercise training decreased the number of apnea-hypopnea events per hour, 
improved oxygen saturation, improved subjective quality of life, and decreased muscular 
sympathetic nerve activity in patients with OSA but not CSA.  
A more recent randomized control trial by Kline and colleagues (2011) recruited 
43 sedentary and obese adults with moderate to severe OSA. The participants were 
randomly chosen to be in an exercise training group or stretching group. The exercise 
training group met four times per week for 12 weeks and performed a total of 150 
minutes of moderate intensity aerobic exercise per week. The exercise training group also 
performed resistance training following aerobic training two days per week. The 
participants in the stretching group met twice per week for 12 weeks to perform whole-
body flexibility exercises.   
OSA severity was determined by overnight polysomnography before and after the 
12-week interventions. The study found that exercise training resulted in a significant 
decrease in the number of apnea hypopnea episodes (32.2 ± 5.6 to 24.6 ± 4.4) per night 
and consequent improvements oxygen saturation as well as improvements in subjective 
sleep quality. No significant changes were seen in any variables in the stretching group. 
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Interestingly, reductions in OSA were not seen with simultaneous reductions in body 
weight; however, significant improvement in body composition were seen.   
A similar randomized control trial study by Sengul and colleagues (2011) 
recruited 20 patients with mild to moderate OSA. The participants were randomized into 
either an exercise or control group.  The exercise group performed aerobic exercise three 
days per week for 12 weeks, with the exercise lasting 1.5 hours per day.  The severity of 
OSA was analyzed via polysomnography before and after the 12-week intervention in 
both groups. Following the intervention, the exercise group demonstrated significant 
decreases in the number of apnea hypopnea events per night while significantly 
increasing subjective sleep scores. The control group saw no significant changes from pre 
to post intervention.  Similar to the study by Kline and colleagues (2011), the experiment 
showed improvements in OSA without decreases in body weight or body composition.   
In conclusion, the discussed experimental studies demonstrate that exercise in 
OSA patients improves neurovascular function, subjective sleep quality, and objective 
sleep quality. These effects occurred independent of decreases in body weight.  
Mechanisms and Implications of Apnea Hypopnea Episodes. The mechanisms 
by which exercise decreases the number apnea hypopnea episodes per night is not fully 
understood but a variety of different theories have been proposed. One possibility is that 
exercise training reduces fluid accumulation in the neck, increasing the diameter of the 
upper airways and preventing collapse (Shiota et al., 2007). In the study discussed 
previously by Ueno et al. (2009), it was found that exercise training increased left 
ventricular ejection fraction in subjects with OSA, indicating the possibility that 
improved cardiac function may reduce edema in the upper airways and improve OSA.   
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Mechanisms and Implications of Hypertension and Cardiovascular Disease. 
Another possibility is that reduced sympathetic nerve activity from exercise training may 
improve OSA. It is well established and accepted that OSA leads to enhanced 
sympathetic activity which is associated with increased cardiovascular disease risk. The 
mechanism by which OSA increases sympathetic activity is likely through two pathways. 
The first and acute pathway being that an increased hypoxic state in OSA stimulates 
carotid body chemoreceptors during sleep which activate sympathetic nerve activity. The 
second and long-term pathway is through increased angiotensin II which directly 
stimulates the carotid body chemoreceptor and sensitizes it. This sensitization likely 
occurs by direct influence of angiotensin II or through activation of NADPH oxidase and 
increased reactive oxygen species. In either case, angiotensin II sensitizes the carotid 
chemoreceptor and causes a sustained increase in sympathetic nerve activity seen during 
arousal.  
 The previously discussed study by Ueno and colleagues (2009) found that 
exercise training suppressed sympathetic nerve activity. This suppression may have been 
from decreased angiotensin II and increased nitric oxide which has been previously 
demonstrated in exercise research. Nitric oxide has been shown to play an inhibitory role 
in the carotid body chemoreceptor in keeping it desensitized. Besides angiotensin II 
directly sensitizing the carotid body chemoreceptor, it also does so indirectly by 
decreasing nitric oxide levels. Thus, by decreasing angiotensin II and increasing nitric 
oxide, it is possible that exercise desensitizes the carotid body chemoreceptor and 
consequently decreases sympathetic nerve activity. A decreased sympathetic state while 
sleeping may decrease the frequency of arousal and improve symptoms of OSA patients. 
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 Independent of the exact mechanism, it is clear exercise training decreases 
sympathetic nerve activity in OSA patients which is of significant benefit due to the 
relationship of OSA and cardiovascular disease. Overwhelming evidence suggests OSA 
causes the development or worsens cardiovascular disease in the form of atherosclerosis, 
hypertension, and stroke (Punjabi et al., 2008). Much of the OSA cardiovascular sequalae 
is a product of increased sympathetic activity. Thus, exercise decreasing sympathetic 
nerve activity may have profound influence over decreasing cardiovascular disease risk 
in OSA patients.     
Further Considerations. Numerous studies have demonstrated that exercise 
training in obese participants results in decreased inflammatory cytokines.  These 
findings are significant in that previous research has demonstrated a strong relationship 
between inflammatory cytokines and the development of insulin resistance. Interestingly, 
elevated levels of inflammatory cytokines and insulin resistance have been seen in OSA 
patients suggesting that OSA may cause their production independent of obesity.  
Besides inflammatory cytokines, the production of reactive oxygen species is also 
believed to be involved in the inflammatory process which drives insulin resistance 
(Yuan et al., 2001). As discussed previously, reactive oxygen species have been shown to 
be elevated in OSA patients likely due to the intermittent hypoxic states and angiotensin 
II/ NADPH oxidase pathway. Future research should examine if exercise training 
specifically in OSA patients influences inflammatory cytokines, angiotensin II, and 
reactive oxygen species.  
While the consequences of untreated OSA are significant, research has provided 
insight into possible modalities which look promising in decreasing the severity or 
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entirely attenuating OSA. One modality which looks particularly promising is that of 
physical activity which has shown to decrease the number of apnea hypopnea events per 
night, decrease sympathetic nerve activity, increase subjective sleep quality, and improve 
overall quality of life. Future research may expand on specific mechanisms by which 
exercise improves OSA, as well as exercise implications in specific diseases related to 
OSA such as cardiovascular disease and diabetes. 
Physical Activity Questionnaires  
It is well established that physical activity has positive effects on many aspects of 
health (Piercy et al., 2018). Despite this understanding, many challenges exist in gauging 
the physical activity levels and general fitness of patients within clinical settings. Most 
traditional forms of physical activity assessment are very involved, time consuming, and 
consequently impractical within the healthcare setting where healthcare providers already 
have little time (Smith et al., 2005; Glasgow et al., 2005). This is why any tool used to 
measure physical activity levels within the healthcare setting must be quick and efficient.  
Considering the impracticality of objective measures for physical activity 
measurement within clinical settings, physical activity levels most often are measured 
subjectively through questionnaires. Most questionnaires utilized within clinical settings 
ask questions regarding the frequency and type of physical activity performed during the 
previous seven days. The frequency and type of activity are then added to measure total 
activity over the course of a typical week. This can be difficult for many patients to 
report, especially more sedentary patients who are unfamiliar with physical activity 
intensities.  
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 Unsurprisingly, physical activity questionnaires are currently used to gauge 
activity levels of OSA patients in clinical settings and in clinical research (Basta et al., 
2008; Batoll-Anwar et al., 2014; Bamberga et al., 2015; Theorell-Haglow et al., 2011). 
This may be problematic due to the fact OSA patients tend to have increased levels of 
sleepiness which decrease the ability to concentrate which may decrease the accuracy of 
the questionnaires (Lindberg and Gislason, 2000). Considering these factors, it should not 
be assumed that a previously validated questionnaire will be valid within the OSA 
population. This issue can be seen in previous research which has relied on previously 
validated questionnaires to measure activity levels within the OSA population (Basta et 
al., 2008; Batoll-Anwar et al., 2014; Bamberga et al., 2015; Theorell-Haglow et al., 
2011).  
A study by Batool-Anwar and colleagues (2014) examined the influenced of 
CPAP on physical activity patterns. In order to accomplish this, they recruited 231 
participants with moderate to severe OSA and randomly assigned them to either a CPAP 
group which utilized CPAP or a CPAP sham group which believed they were utilizing 
CPAP but were not. Participation lasted four months and activity levels via questionnaire 
were taken before and after. The study found that those who used their CPAP also 
increased their physical activity levels. 
Similar to the study by Batool-Anwar and colleagues (2014), Bamberga and 
colleagues (2015) also attempted to understand the relationship between CPAP use and 
physical activity levels. In their study, 107 obese OSA patients were recruited and 
received CPAP for 6 months. Physical activity levels were gauged before and after the 
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study via questionnaires. No increase in physical activity was found, directly contrary to 
the study by Batool-Anwar and colleagues (2014).  
Numerous studies have relied on unvalidated physical activity questionnaires to 
make claims about the OSA population and some studies have unsurprisingly produced 
conflicting results (Batoll-Anwar et al., 2014 and Bamberga et al., 2015). This begs the 
question of whether physical activity questionnaires are a valid measure of physical 
activity levels within the OSA population. It is possible that factors discussed previously, 
such as sedentary lifestyles and sleepiness resulting in a lack of concentration may 
impede the ability of those with OSA from accurately taking physical activity 
questionnaires. Thus, the validity of different physical activity questionnaires within the 
OSA population must be examined in order to determine if it is appropriate to continue to 
gauge activity levels of OSA patients through questionnaires.  
When determining which questionnaires to examine, one must consider the 
limited amount of time that exists within clinical settings and that patients typically come 
from varying educational backgrounds (Smith et al., 2005; Glasgow et al., 2005). This 
would imply that effective questionnaires must be both short and applicable to the 
population as a whole, especially those with low health literacy. Two questionnaires 
which appear promising in being concise and containing questions which are common 
across the general population are the International Physical Activity Questionnaires – 
short form (IPAQ-SF) and Physical Activity Vital Sign (PAVS) (Pereira et al., 1997; 
Marshall et al., 2003; Ball et al., 2016). 
IPAQ-SF. While there are numerous questionnaires which measure physical 
activity in adults, not many meet the criteria of being short and containing questions 
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which are common across the general population (Marshall et al., 2003). The 
International Physical Activity Questionnaire (IPAQ) was developed with these problems 
in mind and was formulated to analyze physical activity levels based on universal 
standards (Craig et al., 2003). The IPAQ has since become one of the most widely used 
questionnaires for measuring physical activity (Poppel et al., 2010). Presently there is a 
short and long version of the IPAQ available for use.  
Both the short and long form ask questions pertaining to the type and amount of 
physical activity done over the course of the previous 7 days. The major difference 
between the two forms is the short form only records absolute levels of each type of 
physical activity and the long form stratifies activity types into either job related, 
transportation, housework, or recreation. Due to the simpler nature of the short form, it is 
more appropriate for a clinical setting where time is limited (Smith et al., 2005; Glasgow 
et al., 2005). Many studies have been conducted on the IPAQ-SF to determine its 
reliability and criterion validity by correlating its results with an objective measure of 
accelerometry and have found the IPAQ-SF to be reliable and valid (Lee et al., 2011).  
In a large population study by Craig and colleagues (2003) the IPAQ-SF was 
examined for reliability and validity across 12 countries within 18-65-year-old adults. 
The study analyzed reliability by giving participants the questionnaire two times over the 
course of one week and found strong reliability (Spearman’s ρ values clustered around 
0.80). Validity was examined by comparing the IPAQ-SF results with accelerometry 
from over the course of one week and had a median of ρ = 0.3, which the authors 
suggested was acceptable compared to exiting self-report questionnaires, especially when 
considering the diversity of the sample. 
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A study by Vandelanotte and colleagues (2005) recruited fifty-three 18-65 year 
old adults in order to analyze the reliability and validity of the IPAQ-SF. In this study 
each participant completed a computerized and paper version of the IPAQ-SF on three 
separate occasions and wore an accelerometer over the course of 7 days in order to 
collect objective data. The study found moderate to strong reliability (ICC between 0.60 
to 0.83) and moderate validity of the IPAQ-SF (r = 0.38).  
In a study by Scheeres and colleagues (2009) the validity of the IPAQ-SF was 
examined in patients with chronic fatigue syndrome. This population presents similar 
characteristics to the OSA population in terms of fatigue. When comparing the results of 
the IPAQ-SF with accelerometry, moderate validity was found (ρ = 0.33).   
A study by Ekelund and colleagues (2006) recruited 185 adults between the ages 
of 20-69 to examine the validity of the IPAQ-SF. All participants wore an accelerometer 
for seven consecutive days and completed the IPAQ-SF on the eighth day. When IPAQ-
SF data was compared to accelerometry data, moderate validity was found. 
A study by Igelstrom and colleagues (2013) examined the validity of the IPAQ-
SF within the obese OSA population. The study recruited 39 participants who were obese 
and had moderate to severe OSA. Each participant completed the IPAQ-SF after 
completing 5 days of activity tracking with an accelerometer. While the study did not 
find a strong relationship between the IPAQ-SF and accelerometry, the study may have 
been inaccurate for multiple reasons. It did not use ActiGraphy and rather used an 
armband which has been shown to not be as valid as hip worn accelerometry. The study 
also only tracked five days of activity when the IPAQ-SF asks about the previous seven 
days of activity.   
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PAVS. Another questionnaire which has proven to be valid within the general 
population is the Physical Activity Vital Sign (PAVS) questionnaire (Coleman et al., 
2012; Ball et al., 2015; Ball et al., 2016; Ball et al., 2016). The PAVS is a self-reported 
physical activity questionnaire that records the type and amount of physical activity 
performed over the previous 7 days. Presently two different versions of the PAVS exist. 
The first version of the PAVS asks two questions to patients, which are “On average, 
how many days per week do you participate in moderate or greater physical activity (like 
a brisk walk)?” and “On those days, how many minutes do you participate at that level?”. 
Physical activity levels are then quantified by multiplying activity performed in minutes 
per day by average days a week.  
A newer second version of the PAVS, depicted in figure 2, was recently 
developed to stratify activity type rather than simply look at total activity (Bal et al., 
2016). The second PAVS records the type and amount of physical activity performed 
over the previous 7 days by asking three questions which are “Please describe your level 
of physical activity by minutes per day”, “number of days each week” and “at what 
intensity (how hard): light (like a casual walk), moderate (like a brisk walk), or vigorous 
(like a jog/run)?”. 
Compared to the IPAQ-SF, the PAVS is a relatively new physical activity 
questionnaire with fewer studies that have examined its validity and reliability. Research 
that has examined the PAVS demonstrates promise. The PAVS usefulness within clinical 
settings is well established as demonstrated by its use within the Kaiser and 
Intermountain Health healthcare systems. 
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In a study by Ball and colleagues (2016) 45 healthy adults were recruited to 
examine the criterion validity of the PAVS. Participants wore an accelerometer for seven 
consecutive days followed by the completion of the PAVS. PAVS data were compared to 
the accelerometry data and strong validity were found (r = 0.52). The PAVS has also 
been studied by Coleman and colleagues (2012) to determine its construct validity by 
comparing its results with BMI and disease burden. This study examined the medical 
records of 1,793,385 adults 18 and older and found that those who exercised less had 
higher disease burden and BMI.  
Figure 2. PAVS  
 
Physical Activity Logbooks  
Physical activity logbooks (or diaries) have long been used as a means to evaluate 
physical activity levels in a variety of populations (Reiff et al., 1967; Sallis, 1991; Tager 
et al., 1998; Sternfeld et al., 1999). In general, the process typically requires participants 
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to log their physical activity in real time in terms of type, frequency, intensity, and 
duration.  
Previous research has indicated there are a variety strengths and weaknesses to 
utilizing logbooks to measure physical activity (Ainsworth, 2009; Sylvia et al., 2013). 
One major benefit to their utilization is that they are less susceptible to recall errors when 
compared to self-report questionnaires (Sylvia et al., 2013). They also provide detailed 
records of activity that self-report questionnaires are not capable of giving (Ainsworth, 
2009; Sylvia et al., 2013). Additionally, they provide context to objective physical 
activity measures when utilized simultaneously (Hagstromer et al., 2006; Igelstrom et al., 
2013). Some limitations to their use are that they can be time consuming and have been 
shown to result in large over predictions of moderate to vigorous physical activity 
(Buchowski et al., 1999; Hagstromer et al., 2006; Igelstrom et al., 2013). A review of the 
published literature identifies three studies that have examined the accuracy of logbooks 
as a means to assess physical activity within OSA and overweight populations.    
A study by Buchowski and colleagues (1999) recruited 115 normal and 
overweight males and females. All participants spent a full day inside a whole room 
indirect calorimeter. Participants were instructed to exercise throughout the day and keep 
a log of the intensity, type, and duration of activity. The logbook results were converted 
into energy expenditure by the Compendium of Physical Activity and compared to 
indirect calorimetry (Ainsworth et al., 1993). The study found that with increasing body 
fat percentage, over predictions of energy expenditure from moderate to vigorous 
physical activity increased. On average, obese participants over predicted energy 
expenditure from moderate to vigorous physical activity by 100% when compared to 
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indirect calorimetry. This study suggests that physical activity logbooks may result in 
over predictions of moderate to vigorous physical activity, particularly in overweight and 
obese adults.   
A study by Hagstromer and colleagues (2006) recruited 46 middle aged sedentary 
adults to test the criterion validity of the IPAQ-SF against accelerometry over the course 
of one week. In this study, participants were also asked to keep a daily physical activity 
log that included the time, type, intensity, and duration of the activity. Instead of 
providing a minute by minute comparison of the logbook versus the accelerometer, the 
study transformed the logbook activity into metabolic equivalent of tasks (METs). The 
study found that the logbook over predicted total MET hours per week by over five 
hours. While the logbook did provide additional context to the type of activity being 
performed as well as when activity took place during the day, the degree of its over 
prediction suggests that it may not be an effective means of assessing physical activity 
within a middle-aged sedentary population.  
The only study we could identify that utilized a physical activity logbook within 
the OSA population was by Igelstrom and colleagues (2013) who recruited thirty-nine 
OSA patients with moderate to severe OSA. Similar to the study by Hagstromer and 
colleagues (2006), the study examined the validity of the IPAQ-SF against accelerometry 
and additionally asked participants to log the time, type, intensity, and duration of 
physical activity throughout the course of a five day period which was then averaged to 
create seven days of total activity. This study provided a minute by minute comparison of 
moderate to vigorous physical activity from the logbook and accelerometry and found 
that participants estimated that they completed 69 minutes of moderate to vigorous 
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physical activity per day when the accelerometer found that they completed 37 minutes 
per day. This equated to a 32 minutes per day or 3.7 hour per week over prediction of 
moderate to vigorous physical activity. The results of this study are similar to the results 
of the studies by Buchowski and colleagues (1999) and Hagstromer and colleagues 
(2006) which found that logbooks over predict total energy expenditure from moderate to 
vigorous physical activity when compared indirect calorimetry and accelerometry.  
In conclusion, studies examining logbooks as a means to assess physical activity 
levels within OSA and overweight populations have found consistent over predictions of 
moderate to vigorous physical activity when compared to objective measures. While 
logbooks do provide additional context to the type of activity being performed at 
different times of the day and week, they are likely most beneficial if combined with and 
observed next to an objective physical activity measure. 
Summary 
OSA is a serious health disorder with debilitating effects on overall health. While 
the etiology of OSA is complex, excess body weight and physical inactivity have been 
shown to be the strongest risk factors. While CPAP, the most common treatment for 
OSA, is effective in treating many of side effects of OSA, it is not well adhered to and 
has been shown, at a minimum, not to promote weight loss. This is concerning due to the 
fact that excess body weight is the number one risk factor for OSA, and results in many 
of same metabolic disorders and cardiovascular disease which OSA is associated with or 
causes. Research has demonstrated that increased physical activity levels maintain or 
decrease body weight while significantly decreasing the severity of OSA, even when 
body reductions are not realized. In this regard, combining recommendations for exercise 
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and physical activity with CPAP may be a viable means to treat the major side effects of 
OSA and at a minimum ensure the underlying cause does not get worse. Increased 
activity levels would also reduce secondary risk factors that place patients at increased 
risk for worsening of their OSA, metabolic disorders, and cardiovascular disease. 
While physical activity questionnaires are presently the most common method for 
assessing physical activity levels of those with OSA, no questionnaire has been validated 
specifically within the OSA population. Due to their short and simple nature, the IPAQ-
SF and PAVS appear to be promising questionnaires for use in the OSA population. Both 
questionnaires have been shown to be reliable and valid within healthy populations but 
have yet to be thoroughly evaluated within the OSA population.  
Having a validated physical activity questionnaire would provide a quick and 
inexpensive tool for clinicians to accurately determine the amount and patterns of 
physical activity within OSA patients. This would benefit the patients in allowing to get a 
clear picture of their activity levels as well as the clinician in determining how to proceed 
with appropriate protocols for treatment.  It could also serve as a measure for both 
physicians and researchers to determine if future protocols aimed at increasing physical 
activity levels of OSA patients are effective.   
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Chapter 3: Methods 
Introduction 
This study aimed to assess the validity and reliability of physical activity 
questionnaire within the OSA population. Chapter two outlined the current literature to 
support a need for research in this area. To this date, no study had examined the validity 
of the PAVS within the OSA population. The study that did examine the validity of 
IPAQ-SF had many flaws (Igelstrom et al., 2013). The review of literature supports the 
following design.  
Research Design  
The study design allowed for investigation of the criterion validity, construct 
validity, and reliability of the IPAQ-SF and PAVS within an OSA population. The study 
used a descriptive correlation research design. Criterion validity was examined by 
determining the relationship between the IPAQ-SF and PAVS, which served as the 
subjective measures, and accelerometry data collected over the course of one week, 
which served as the objective measure. The data were assessed using Pearson correlation 
coefficients.  
Construct validity was determined by examining the relationship between the 
IPAQ-SF and PAVS with BMI, CPAP adherence, OSA disease severity, sleepiness, and 
quality of life. The data were assessed by Spearman rank correlation coefficient. 
Reliability of the IPAQ-SF and PAVS was determined by having OSA patients complete 
the questionnaires twice at least seven days apart. These data were assessed by a two-way 
mixed, single measure, parametric intraclass correlation (ICC).  
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Specific Aim 1: To assess the criterion validity of the IPAQ-SF, PAVS, and logbook 
within an OSA population by comparing their results with an objective measure of 
accelerometry over the course of one week. 
Hypothesis 1. IPAQ-SF, PAVS, and logbook will correlate strongly with one 
week of accelerometry data from individuals with OSA.  
Specific Aim 2: To determine reliability of the IPAQ-SF and PAVS within an OSA 
population through a test retest design.  
Hypothesis 2. IPAQ-SF and PAVS will show strong reliability when taken 
two times separated by at least one week. 
Specific Aim 3: To determine construct validity of the IPAQ-SF, PAVS, and logbook 
within an OSA population by comparing the results of the questionnaires with BMI, 
sleepiness, OSA disease severity, CPAP adherence, sedentary time, and quality of life.  
Hypothesis 3. Individuals with OSA that have lower levels of physical activity 
as indicated by the IPAQ-SF and PAVS will have a higher BMI, disease 
severity, and sleepiness while having a lower sleep quality and CPAP 
adherence. 
Specific Aim 4: To determine the relationship between objective physical activity levels 
and BMI, sleepiness, OSA disease severity, CPAP adherence, and quality of life. 
Hypothesis 4. Individuals with OSA that have lower levels of physical activity as 
indicated by accelerometry will have a higher BMI, disease severity, and 
sleepiness while having a lower sleep quality and CPAP adherence. 
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Population and Sample   
Participants. Following approval by the institutional review board, a 
convenience sample of 40 individuals with OSA between the ages of 18-65 were 
recruited as the experimental group. Participants were recruited from the Indianapolis 
area through word of mouth, email, flyers, and the assistance of Indiana Clinical and 
Translational Sciences Institute (CTSI)”. Interested participants were requested to contact 
the researcher via email to determine eligibility and to schedule an appointment to begin 
the study.  
Inclusion and Exclusion Criteria. Inclusion criteria for participation in the study 
included individuals: (a) who were male or female between 18-65 years of age, (b) who 
could read and write English, (c) who had been diagnosed with moderate to sereve OSA 
(AHI ≥ 15). Exclusion criteria included individuals: (a) not meeting the above criteria, (b) 
with recent or chronic restrictive musculoskeletal injury (i.e. fractures, severe sprains or 
strains, dislocations, subluxations, or connective tissue injury), (c) those diagnosed with 
memory problems or diseases.  
Instrumentation  
 IPAQ short form.  The IPAQ-SF is a seven-item self-report physical activity 
questionnaire. The questionnaire assesses physical activity levels during the previous 
seven days. Frequency and duration of vigorous, moderate, and walking activity are 
assessed. The total physical activity time spent at different intensities are determined by 
multiplying the frequency and duration of each. Total physical activity time over the 
course of the week is calculated by adding all categories.  
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PAVS. The PAVS is a self-report physical activity questionnaire that records the 
type and amount of physical activity performed over the previous seven days. Presently 
two different versions of the PAVS exist. The initial version of the PAVS asks two 
questions to patients, which are “On average, how many days per week do you participate 
in moderate or greater physical activity (like a brisk walk)?” and “On those days, how 
many minutes do you participate at that level?”. Physical activity levels are then 
quantified by multiplying activity performed in minutes per day by average days a week.  
The more recent version of the PAVS, which was used in the current study, was 
altered to be more specific to the type of physical activity being done (Ball et al., 2013). 
This version consists of three questions which are “Please describe your level of physical 
activity by minutes each day and number of days each week” and “at what intensity (how 
hard): light (like a casual walk), moderate (like a brisk walk), or vigorous (like a 
jog/run)?” Physical activity levels are then quantified by multiplying the type of activity 
performed in minutes per day by average days a week. 
ActiGraph. Accelerometry is the most commonly used objective measure for the 
determination of physical activity levels, with numerous studies demonstrating its 
validity (Freedson et al., 1998; Hendelman et al., 2000; Rothney et al., 2008; Sasaki et 
al., 2011). The ActiGraph wGT3X-BT (ActiGraph, LLC, Pensacola, Florida, USA) was 
the accelerometer used in the study. The ActiGraph is a 3-axis hip-worn accelerometer 
(4.6 cm x 3.3 cm x 1.5 cm, with a weight of 19 grams) that records accelerations ranging 
from 0.05 to 2 g. The ActiGraph is initialized and downloaded by ActiLife 6 software. 
Studies have demonstrated that the ActiGraph is valid by showing strong correlation with 
energy expenditure during daily activity. The ActiGraph has also been shown to have 
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strong test-retest reliability (ICC = 0.80), and when it is worn for seven consecutive days, 
physical activity can be assessed with 90% reliability. The ActiGraph does not provide 
the user with any feedback, and the ActiGraphs used in this study was calibrated by the 
manufacturer prior to the start of the study. (Sasaki et al., 2011; Santos-Lozano et al., 
2013). 
Health Related Quality of Life. The Healthy Days core questionnaire is a 4-item 
questionnaire created by the Center for Disease Control and Prevention to examine 
quality of the life. The questionnaire asks about mental and physical quality. Specifically, 
participants list the number of days in the previous month where they felt physically or 
mentally unhealthy.  The questionnaire provides a score between 0 and 30 days, with 
scores closer to zero indicating a higher quality of life and scores closer to 30 indicating a 
lower quality of life. The questionnaire has been used in the State-based Behavioral Risk 
Factor Surveillance System since 1993, in the National Health and Nutrition Examination 
Survey since 2000, and in the Medicare Health Outcome Survey since 2003 (CDC, 
2019). For this reason, the questionnaire was used in the study to determine if a 
relationship between more severe OSA and a lower quality of life. 
Epworth Sleepiness Scale. The Epworth sleepiness scale is a questionnaire 
designed by Dr. Murray Johns in 1990 (Johns, 1991). The questionnaire was named after 
Epworth hospital in Melbourne Australia. In designing the questionnaire, Johns’ intent 
was to create a tool, which could accurately assess daytime sleepiness. The questionnaire 
presents eight different circumstances which patients must rank their likeness of dozing 
off in. Patients rank on a four-point scale (0-3) with a score of zero indicating no chance 
of dozing off and a score of three indicating a high chance of dozing off. The 
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questionnaire results in a score between zero and 24, with scores closer to zero indicating 
low levels of sleepiness and scores closer to 24 indicating high levels of sleepiness. 
Studies examining the Epworth Sleepiness scale have found it be reliable with 
intraclass correlation coefficients between 0.81 and 0.93 (Gibson et al. 2006; Izci et al. 
2007; Cho et al 2011; van der Heide et al. 2015). In terms of the relationship between the 
Epworth Sleepiness Scale and OSA, studies have found both statically significant and 
statically non-significant relationships (Manni et al 1999; Guilleminault et al, 1988). 
Nonetheless, the scale is used frequently to help predict the likeliness of whether a patient 
will be diagnosed with OSA. For this reason, the questionnaire was used in the study to 
examine if a relationship between physical activity levels and sleepiness existed. 
Study Procedures  
 Initial contact. Patients were informed about the study through word of mouth, 
flyers, and the assistance of Indiana Clinical and Translational Sciences Institute (CTSI). 
Interested participants contacted the researcher through email. The researcher then 
determined eligibility of the potential participant. If eligible, the participant made two 
separate visits, which were both conducted by the researcher.  
First Visit. Upon arrival to the laboratory on the first visit, participants were 
provided voluntary written informed consent which can be found in appendix 9. 
Following consent, participants then completed the IPAQ-SF and PAVS.  Each 
participant was then fitted with a belt around the waist that served as the attachment point 
for the ActiGraph. Participants were instructed to wear the ActiGraph, which was 
initialized at a sample rate of 30 Hz to record activities for free-living conditions, over 
their right iliac crest during all waking hours for the next seven consecutive days, except 
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when showering, bathing or swimming. Participants were instructed to remove the 
ActiGraph when going to bed at night and to record what time they put on and removed 
the ActiGraph each day onto a log sheet.  
Construct Validity. The PAVS and IPAQ-SF were examined for construct 
validity by comparing the questionnaires with BMI, sleep quality, OSA disease severity, 
treatment adherence, and quality of life. In order for the researcher to access this 
information, each participant completed an authorization for the release of health 
information for research form. This form was provided to the participants’ doctor who 
provided the information needed for the determination of construct validity. 
Second visit. Following the seven days, participants met with the researcher a 
second time to return the Actigraph, and complete the IPAQ-SF and PAVS for the second 
time.  
Data Analysis    
SPSS version 26 (IBM, Richmond, Virginia) was used for data analysis. 
Differences in age, BMI, and activity levels were examined between genders using 
independent t-tests. Accelerometry data were downloaded and analyzed using ActiLife 6 
software (ActiGraph, LLC, Pensacola, Florida, USA). Waking minutes from the 
ActiGraph were cleaned by application of a separate non-wear algorithm to identify valid 
wear time during waking hours. Participants with a wear time corresponding to at least 10 
hours during waking time per day (i.e., ≥600 total wear min/day), collected over seven 
full days or more were included in analyses.  Counts per minute were summed across 
seven days in order to determine total hours and minutes of activity over the course of the 
week. As depicted in table 1, the Freedson cut-points (light <1952 counts/minute, 
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moderate 1952–5724 counts/minute, vigorous > 5725 counts/ minute) were used to 
stratify intensities (Freedson et al., 1998). These cut-points were used because the 
moderate intensity category is calibrated to walking, which is the most common type of 
ambulatory activity. Because the current physical activity recommendations no longer 
indicate that physical activity must be accumulated in bouts of at least 10 minutes, the 
data were examined as a whole to determine the number of minutes per day spent in 
moderate and vigorous physical activity and not just those that occur in bouts of at least 
10 minutes.  
Table 1. Freedson cut points  
Counts Per Minute  Activity Level 
Less than 1952 Light 
1952 – 5724 Moderate 
Greater than 5725 Vigorous  
 
Criterion validity. Criterion validity of the IPAQ-SF and PAVS was assessed by 
Pearson correlation coefficient. Results of the IPAQ-SF and PAVS were compared with 
physical activity data as collected by the ActiGraph (r < 0.3 = None or very weak, 0.3 < r 
<0.5 = small 0.5 < r < 0.7 = Moderate, r > 0.7 = strong) (Hojat and Xu, 2004). 
Judgements of the significance of the correlations were further examined using Bland-
Altman plots (Bland and Altman, 1986). The Bland-Altman plots provided indication of 
the systematic and random error and heteroscedasticity of the data and 95% limits of 
agreement for describing the total error between the questionnaires and ActiGraph.  
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Reliability. Reliability of the I-PAQ-SF and PAVS was assessed by a two-way 
mixed, single measure, parametric intraclass correlation (ICC) (ICC < 0.5 = poor, 0.5 < r 
<0.75 = moderate, 0.75 < r < 0.9 = good, r > 0.9 = excellent) (Bartko, 1976). 
Construct Validity. Construct validity of the I-PAQ-SF and PAVS was assessed 
by Spearman rank correlation coefficient (ρ). Results of the IPAQ-SF and PAVS were 
compared with BMI, OSA severity, CPAP adherence, quality of life, and sleepiness (ρ < 
0.3 = None or very weak, 0.3 < ρ <0.5 = small 0.5 < ρ < 0.7 = moderate, ρ > 0.7 = 
strong) (Hojat and Xu, 2004). 
Sample Size. A power analysis was performed for the determination of sample 
size and is depicted in table 2. For the determination of construct and criterion validity, 
effect size was set at 0.5 which was based on existing research where the correlation 
coefficients for the IPAQ-SF and PAVS when compared to accelerometry data averaged 
0.5 (Ball et al., 2014). Level of significance was set at less than 5 percent, and power was 
set at 80%. It was determined that a minimum of 37 participants were required for the 
current study in order achieve the necessary power.  
Table 2. Power Analysis 
Measure  A Priori  
Effect Size  0.5 Medium 
Alpha (α) 0.05 
Power (1-β) 0.80 
Sample size total 37 
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Chapter 4: Results  
Introduction  
 A schematic of participant enrollment and adherence is shown in figure 3. 
Between March and July 2019, a total of 40 participants were enrolled (Figure 3). After 
examining the raw data, one participant did not meet the minimum criteria for 
accelerometry wear time and was excluded from all data analyses. The participant was 
asked to wear the accelerometer for an additional seven days but did not have an interest 
in doing so. A total of 39 participants completed the study with adequate amounts of wear 
time. The measures and associated statistical tests are listed in table 3. 
Figure 3. Participant enrollment and adherence  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Participants consented, N = 40 
(Male = 14, Female = 26) 
Visit 1  
Questionnaires completed 
ActiGraphs distributed  
Visit 2 - 7 days later 
Questionnaires completed 
ActiGraphs returned   
Inadequate amount of data 
from ActiGraph, N =1  
 (Female = 1) 
Adequate amount of data 
from ActiGraph, N = 39 
(Male = 14, Female = 25) 
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Table 3. Statistical analysis for each measure 
Type of measure  Comparison  Analysis  
Criterion validity  IPAQ-SF visit 2 versus 
ActiGraph  
Pearson correlation  
 
Bland Altman plot 
Reliability  IPAQ-SF visit 1 versus visit 
2  
two-way mixed, single 
measure, parametric 
intraclass correlation 
Construct validity IPAQ-SF visit 2 versus 
variables related to the 
outcome  
Spearman correlation  
Criterion validity  PAVS visit 1 versus 
ActiGraph 
Pearson correlation  
 
Bland Altman plot 
Reliability  PAVS visit 1 versus visit 2  two-way mixed, single 
measure, parametric 
intraclass correlation 
Construct validity  PAVS visit 2 versus variables 
related to the outcome 
Spearman correlation  
Criterion validity  Logbook versus ActiGraph Pearson Correlation  
 
Bland Altman plot 
Construct validity  Logbook versus variables 
related to the outcome  
Spearman correlation  
Exploratory  ActiGraph versus variables 
related to the outcome  
Spearman correlation  
 
Sample  
Descriptive statistics for participants are reported in table 4. There were 14 males 
and 25 females for a total of 39 participants. The age range for participants was between 
25 and 65 years with an average age of 51.5 ± 9.5 years. All participants were either 
overweight or obese with the BMI ranging between 27 and 61 and averaging 39.1 ± 8.8. 
All participants had moderate to severe OSA, with AHI values ranging between 15 and 
128, and averaging 40.4 ± 29.3. Unhealthy days for participants ranged between 0 and 30 
days per month and averaged 11.6 ± 11.7. Sleepiness levels ranged between 0 and 20 and 
averaged 8.1 ± 4.8. Every participant in the study scored 10 out of 10 on the cognitive 
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impairment questionnaire. The descriptive statistics indicated normal distribution for age, 
BMI, OSA severity, and physical activity levels. There were no significant gender 
differences regarding age (p = 0.88), BMI (p = 0.71), or time spent in moderate-to-
vigorous activity (p = 0.63) as reported by the questionnaires or ActiGraph. 
Consequently, the genders were pooled in analyses.   
 
Specific Aim 1. To assess the criterion validity of the IPAQ-SF, PAVS, and logbook 
within an OSA population by comparing their results with an objective measure of 
accelerometry over the course of one week. 
Since both the questionnaires and ActiGraph measured weekly activity in minutes 
per week, which are discrete variables, Pearson correlations were used to assess the 
validity of the questionnaires and logbook by comparing their results with physical 
activity data collected by the ActiGraph. Moderate, vigorous, and moderate-to-vigorous 
Table 4. Characteristics of participants, n = 39  
Male 14 
Female 25 
African American  12 
Caucasian 27 
Age (years) 51.5 ± 9.5 
Height (cm) 168.7 ± 10.6  
Weight (kg) 111.3 ± 21.8 
Body Mass Index  39.1 ± 8.8 
Time Since Diagnosis  .7 ± 1.8 
ActiGraph Wear Time (h week-1)  14 ± 3.7 
OSA Severity (AHI) 40.4 ± 29.3 
Quality of Life* (QofL) (unhealthy days) 11.6 ± 11.7 
CPAP Adherence (h week-1) 38.63 ± 21.6 
Sleepiness**  8.1 ± 4.8 
Cognitive Impairment*** 10 ± 0  
Values are expressed as mean ± standard deviation (except 
for frequencies) 
 
*QofL measured by the Health Days Questions (range: 0-30)  
**Sleepiness measured by the Epworth Sleepiness Scale (range: 0-24) 
*** Cognitive impairment measured by the Short Portable Mental Status 
Questionnaire (0-10)  
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physical activity levels were determined by adding together activity types as written on 
the questionnaires. Activity levels from the ActiGraph were determined by downloading 
the raw data and running it through ActiLife 6 software using the 1998 Freedson cut 
points which stratified activity levels into moderate, vigorous, and moderate-to-vigorous.  
 Descriptive and correlational results for the IPAQ-SF are reported in tables 5 and 
6. For the IPAQ-SF, moderate activity levels were 332.8 ± 481.7 minutes a week, while 
moderate activity levels from the ActiGraph were 109.1 ± 122.2 minutes per week. This 
resulted in a Pearson correlation coefficient of 0.406 and a p value of 0.01 for moderate 
activity. Vigorous activity levels as measured by the IPAQ-SF were 121.7 ± 403.3 
minutes per week, while vigorous activity levels from the ActiGraph were 1.6 ± 5.1 
minutes per week. This resulted in a Pearson correlation coefficient of 0.02 and a p value 
of 0.919 for vigorous activity. Moderate-to-vigorous activity levels measured by the 
IPAQ-SF were 454.5 ± 772 minutes per week, while moderate-to-vigorous activity levels 
measured by the ActiGraph were 110.8 ± 124.9 minutes per week. This resulted in 
Pearson correlation coefficient of 0.569 and a p value of <0.001 for moderate-to-vigorous 
activity 
Table 5. Descriptive data from the IPAQ-SF and ActiGraph  
 IPAQ-SF ActiGraph  
Total MVPA (min week -1) 454.5 ± 772 110.8 ± 124.9 
Moderate PA (min week -1) 332.8 ± 481.7 109.1 ± 122.2 
Vigorous PA (min week -1) 121.7 ± 403.3 1.6 ± 5.1 
Values are expressed as mean ± standard deviation  
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Table 6. Pearson correlation coefficients PAVS and ActiGraph  
IPAQ-SF vs ActiGraph  r 
Total MVPA  0.569*** 
Moderate PA  0.406** 
Vigorous PA  0.02 
**, P < 0.01; ***, P < 0.001 
 
 A Bland-Altman plot (figure 4) was created to analyze moderate-to-vigorous 
activity from the IPAQ-SF and ActiGraph. The analysis showed that the mean difference 
between the IPAQ-SF and ActiGraph for moderate-to-vigorous physical activity was 
345.8 minutes per week, indicating participants generally overestimated their moderate-
to-vigorous physical activity levels by over 4-fold using the IPAQ-SF. The 95% limits of 
agreement were wide, ranging from -1045.7 to 1737.4 minutes per week.   
Figure 4. Bland Altman plot for IPAQ-SF vs ActiGraph 
 
Descriptive and correlational results for the PAVS are reported in tables 7 and 8. For the 
PAVS, moderate activity levels measured 112.1 ± 156.9 minutes per week, while 
moderate activity measured from the ActiGraph were 109.8 ± 122.4 minutes per week. 
This resulted in a Pearson correlation coefficient of 0.693 and p value of <0.001 for 
moderate activity. Vigorous activity levels as measured by the PAVS were 46.1 ± 230.1 
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minutes per week, while vigorous activity levels from the ActiGraph were 1.6 ± 5.1 
minutes per week. This resulted in a Pearson correlation coefficient of 0.04 and p value 
of 0.815 for vigorous activity. Moderate-to-vigorous activity levels as measured by the 
PAVS were 159.3 ± 337.2 minutes per week, while moderate-to-vigorous activity levels 
from the ActiGraph were 111.3 ± 125.2 minutes per week. This resulted in a Pearson 
correlation coefficient of 0.802 and p value of <0.001 for moderate-to-vigorous activity. 
Table 7. Descriptive data from the PAVS and ActiGraph  
 PAVS  ActiGraph  
Total MVPA (min week -1) 159.3 ± 337.2 110.8 ± 124.9 
Moderate PA (min week -1) 112.1 ± 156.9 109.1 ± 122.2 
Vigorous PA (min week -1) 46.1 ± 230.1 1.6 ± 5.1 
Values are expressed as mean ± standard deviation  
 
 Table 8. Pearson correlation coefficients for PAVS and ActiGraph 
PAVS vs ActiGraph  r 
Total MVPA  0.802*** 
Moderate PA  0.693** 
Vigorous PA  0.04 
**, P < 0.01; ***, P < 0.001 
 
 A Bland-Altman plot (figure 5) was created to analyze moderate-to-vigorous 
activity from the PAVS and ActiGraph. The analysis showed that the mean difference 
between the PAVS and ActiGraph was 46.8 minutes per week, with PAVS 
overestimating moderate-to-vigorous activity by 43%. The 95% limits of agreement 
ranged from -440.7 to 534.4 minutes per week. 
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Figure 5. Bland Altman plot for PAVS vs ActiGraph 
 
 
 Descriptive and correlational results for the logbook are reported in tables 9 and 10. For 
the logbook, moderate-to-vigorous activity levels measured 302.6 ± 554.9 minutes per 
week, while moderate-to-vigorous activity levels from the ActiGraph were 111.3 ± 125.2 
minutes per week. This resulted in a Pearson correlation coefficient of 0.59 and a p value 
of <0 0.001 for moderate-to-vigorous activity.  
Table 9. Descriptive data from the logbook and ActiGraph 
 Logbook  ActiGraph  
Total MVPA (min week -1) 302.6 ± 554.9 110.8 ± 124.9 
Values are expressed as mean ± standard deviation  
 
Table 10. Pearson correlation coefficients for logbook and ActiGraph 
Logbook vs ActiGraph  r 
Total MVPA  0.59*** 
***, P < 0.001 
 
 A Bland-Altman plot (figure 6) was created to analyze moderate-to-vigorous 
activity from the logbook and ActiGraph. The analysis showed that the mean difference 
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between the logbook and ActiGraph was 191.2 minutes per week. The 95% limits of 
agreement ranged from -772.3 to 1154.7 minutes per week.   
Figure 6. Bland Altman plot for logbook vs ActiGraph 
 
 
Specific Aim 2: To determine reliability of the IPAQ-SF and PAVS within an OSA 
population through a test retest design.  
For aim 2, a two-way mixed, single measure, parametric intraclass correlation 
(ICC) was used to determine if the IPAQ-SF and PAVS were reliable when taken two 
times at least 7 days apart. Establishing reliability of the IPAQ-SF and PAVS within the 
OSA population was important because a questionnaire cannot be valid if it is not 
reliable.  
The reliability statistics for the IPAQ-SF are reported in table 11. For the IPAQ-
SF, moderate activity levels were estimated at 226.7 ± 409.2 minutes per week during the 
first visit and 332.8 ± 481.7 during the second visit, resulting in an ICC of 0.463 and 95% 
confidence intervals of lower bound -0.011 and upper bound 0.717. Vigorous activity 
levels were estimated at 118.6 ± 434 minutes per week during the first visit and 121.7 ± 
403.3 during the second visit, resulting in an ICC of 0.892 and 95% confidence intervals 
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of lower bound 0.794 and upper bound 0.944. Moderate-to-vigorous activity levels were 
estimated at 345.3 ± 668.7 minutes per week during the first visit and 454.5 ± 772 during 
the second visit, resulting in an ICC of 0.766 and 95% confidence intervals of lower 
bound 0.557 and upper bound 0.877. 
Table 11. Reliability of IPAQ-SF 
 Administration 
one 
Administration 
two 
 
ICC 
 
95% CI 
MVPA 345.3 ± 668.7 454.5 ± 772 .766** .557, 0.877 
Moderate  226.7 ± 409.2 332.8 ± 481.7 .463** 0.011, 0.717 
Vigorous  118.6 ± 434 121.7 ± 403.3 .892** .794, 0.944 
values are mean ± sd, *P < 0.05, **P < 0.01 between administrations 
 
The reliability statistics for the PAVS are reported in table 12. For the PAVS, 
moderate activity levels were estimated at 98.0 ± 175.4 minutes per week during the first 
visit and 112.1 ± 156.9 during the second visit, resulting in an ICC of 0.922 and 95% 
confidence intervals of lower bound 0.853 and upper bound 0.959. Vigorous activity 
levels were estimated at 69.9 ± 338.2 minutes per week during the first visit and 46.1 ± 
230.1 during the second visit, resulting in an ICC of 0.958 and 95% confidence intervals 
of lower bound 0.920 and upper bound 0.978. Moderate-to-vigorous activity levels were 
estimated at 167.9 ± 412.8 minutes per week during the first visit and 159.3 ± 337.2 
during the second visit. This resulted in an ICC of 0.982 and 95% confidence intervals of 
lower bound 0.966 and upper bound 0.991. 
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Table 12. Reliability of PAVS 
 Administration 
one 
Administration 
two 
 
ICC 
 
95% CI 
MVPA 167.9 ± 412.8 159.3 ± 337.2 .982** .966, 0.991 
Moderate  98.0 ± 175.4 112.1 ± 156.9 .922* .853, 0.959 
Vigorous  69.9 ± 338.2 46.1 ± 230.1 .958** .920, 0.978 
values are mean ± sd, *P ≤ 0.05, **P < 0.01 between administrations 
 
Specific Aim 3: To determine construct validity of the IPAQ-SF, PAVS, and logbook 
within an OSA population by comparing the results of the questionnaires with BMI, 
sleepiness, OSA disease severity, CPAP adherence, sedentary time, and quality of life.  
Because aim 3 is comparing a discrete variable in physical activity time against 
ranked variables, Spearman rank correlation coefficients were used. The Spearman 
correlation coefficients were run to determine if estimated physical activity levels from 
the questionnaires were related to factors related to OSA, such as BMI, disease severity, 
CPAP adherence, sleepiness, sedentary time, and quality of life. Establishing construct 
validity of the IPAQ-SF, PAVS, and logbook within the OSA population was important 
because it helped determine if the questionnaires were accurate in their overall 
assessment of an OSA patient.   
All constructs compared to activity levels as reported by the IPAQ-SF are 
reported in table 13. For the IPAQ-SF, no significant correlations were found between 
moderate, vigorous, or moderate-to-vigorous physical activity and OSA severity, quality 
of life, CPAP adherence, or sleepiness. The significant correlations found were between 
moderate physical activity and BMI (ρ = -0.279, p = 0.05), and moderate-to-vigorous 
physical activity and BMI (ρ = -0.268, p = 0.05). 
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Table 13. Spearman correlation coefficients for IPAQ-SF versus construct   
IPAQ-SF Construct measure ρ 
Total MVPA (min week -1) BMI 0.268* 
Moderate PA (min week -1) BMI 0.279* 
Vigorous PA (min week -1) BMI 0.04 
Total MVPA (min week -1) OSA severity  .032 
Moderate PA (min week -1) OSA severity  .019 
Vigorous PA (min week -1) OSA severity  .224 
Total MVPA (min week -1) QofL .072 
Moderate PA (min week -1) QofL .098 
Vigorous PA (min week -1) QofL 0.111 
Total MVPA (min week -1) CPAP Adherence 0.003 
Moderate PA (min week -1) CPAP Adherence .007 
Vigorous PA (min week -1) CPAP Adherence  0.242 
Total MVPA (min week -1) Sleepiness .062 
Moderate PA (min week -1) Sleepiness .063 
Vigorous PA (min week -1) Sleepiness 0.096 
*, P ≤ 0.05 
 
All constructs compared to activity levels as reported by the PAVS are reported in 
table 14. For the PAVS, no significant correlations were found between moderate, 
vigorous, or moderate-to-vigorous physical activity and OSA severity, quality of life, 
CPAP adherence, or sleepiness. The significant correlations found were between 
moderate-to-vigorous physical activity and BMI (ρ = -0.273, p = 0.05), and vigorous 
physical activity and BMI (ρ = -0.331, p = 0.05) 
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Table 14. Spearman correlation coefficients for PAVS versus construct   
PAVS Construct measure ρ 
Total MVPA (min week -1) BMI 0.273* 
Moderate PA (min week -1) BMI .245 
Vigorous PA (min week -1) BMI 0.331* 
Total MVPA (min week -1) OSA severity  0.166 
Moderate PA (min week -1) OSA severity  0.157 
Vigorous PA (min week -1) OSA severity  0.112 
Total MVPA (min week -1) QofL 0.042 
Moderate PA (min week -1) QofL 0.097 
Vigorous PA (min week -1) QofL .03 
Total MVPA (min week -1) CPAP Adherence .024 
Moderate PA (min week -1) CPAP Adherence 0.022 
Vigorous PA (min week -1) CPAP Adherence  0.114 
Total MVPA (min week -1) Sleepiness .038 
Moderate PA (min week -1) Sleepiness 0.058 
Vigorous PA (min week -1) Sleepiness .07 
*, P ≤ 0.05 
 
All constructs compared to activity levels as reported by the logbook are reported 
in table 15. For the logbook, no significant correlations were found between moderate-to-
vigorous physical activity and OSA severity, quality of life, CPAP adherence, or 
sleepiness. The significant correlations found were between moderate-to-vigorous 
physical activity and BMI (ρ = -0.343, p = 0.033)  
Table 15. Spearman correlation coefficients for logbook versus construct   
logbook Construct measure ρ 
Total MVPA (min week -1) BMI 0.343* 
Total MVPA (min week -1) OSA severity  .036 
Total MVPA (min week -1) QofL 0.03 
Total MVPA (min week -1) CPAP Adherence .09 
Total MVPA (min week -1) Sleepiness 0.080 
*, P ≤ 0.05 
 
Specific Aim 4. To determine the relationship between objective physical activity levels 
and BMI, sleepiness, OSA disease severity, CPAP adherence, and quality of life. 
Because aim 4 was comparing a discrete variable in objective physical activity 
time against ranked variables, Spearman rank correlation coefficients were used. The 
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Spearman correlation coefficients were run to determine if physical activity levels as 
measured by the ActiGraph were correlated to factors related to OSA, such as BMI, 
disease severity, CPAP adherence, sleepiness, sedentary time, and quality of life. These 
data were examined for the purpose of helping determine future areas of interest for 
research.    
All data for constructs versus activity levels as reported by the ActiGraph are 
reported in table 16. No significant correlations were found between moderate, vigorous, 
or moderate-to-vigorous physical activity and OSA severity, quality of life, CPAP 
adherence, or sleepiness. The significant correlations found were between moderate 
physical activity and BMI (ρ = 0.335, p = 0.034) and moderate-to-vigorous physical 
activity and BMI (ρ = 0.320, p = 0.042). 
Table 16. Spearman correlation coefficients for ActiGraph versus construct   
Activity monitor Construct measure ρ 
Total MVPA (min week -1) BMI 0.320* 
Moderate PA (min week -1) BMI 0.335* 
Vigorous PA (min week -1) BMI 0.204 
Total MVPA (min week -1) OSA severity  0.190 
Moderate PA (min week -1) OSA severity  0.191 
Vigorous PA (min week -1) OSA severity  0.115 
Total MVPA (min week -1) QofL 0.265 
Moderate PA (min week -1) QofL 0.273 
Vigorous PA (min week -1) QofL .051 
Total MVPA (min week -1) CPAP Adherence 0.118 
Moderate PA (min week -1) CPAP Adherence 0.096 
Vigorous PA (min week -1) CPAP Adherence  0.219 
Total MVPA (min week -1) Sleepiness .003 
Moderate PA (min week -1) Sleepiness .007 
Vigorous PA (min week -1) Sleepiness .027 
*, P ≤ .05 
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Summary of Findings  
Table 17 provides a description of the research hypotheses and outcomes. The 
analyses indicated that the relationship between the IPAQ-SF and the ActiGraph was 
significant for moderate-to-vigorous physical activity with a moderate effect size (r > .5). 
The IPAQ-SF was not valid with low effect sizes (r < .5) for determining either moderate 
or vigorous physical activity. The relationship between the PAVS and the ActiGraph was 
significant for moderate and moderate-to-vigorous physical activity with a strong effect 
size for both. The PAVS was not valid for determining vigorous physical activity. The 
relationship between the logbook and the ActiGraph was significant for moderate-to-
vigorous physical activity with a moderate effect size. Unlike the IPAQ-SF and PAVS, 
the logbook did not examine moderate and vigorous physical activity individually.   
The reliability analysis indicated that the IPAQ-SF held good reliability for 
moderate-to-vigorous and vigorous physical activity with wide confidence intervals when 
taken twice over the course of 7 days. The IPAQ-SF was not reliable in determining 
moderate physical activity. The PAVS had excellent reliability for moderate, vigorous, 
and moderate-to-vigorous physical activity with narrow confidence intervals.  
When examining construct validity, levels of moderate, vigorous, and moderate-
to-vigorous activity as reported by the IPAQ-SF, PAVS, and logbook held no relationship 
with OSA severity, CPAP adherence, quality of life, or sleepiness. The only relationship 
the IPAQ-SF, PAVS, and logbook all held was with moderate-to-vigorous physical 
activity and BMI.  
When comparing the accelerometry data to factors related to OSA, it was found 
that objective moderate, vigorous, and moderate-to-vigorous physical activity levels held 
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no relationship with OSA severity, CPAP adherence, quality of life, and sleepiness. The 
only relationship that objective physical activity levels held was with moderate-to-
vigorous physical activity and BMI. 
In reviewing the results for specific aim 1 and 3, the PAVS is the most valid and 
reliable questionnaire when compared to the IPAQ-SF and logbook for determining 
moderate and moderate-to-vigorous physical activity. The IPAQ-SF, PAVS, and logbook 
are not valid in determining vigorous physical activity levels. In terms of specific aim 2, 
the IPAQ-SF, PAVS, and logbook did not produce significant relationships with any 
physical activity level and OSA severity, CPAP adherence, quality of life, or sleepiness. 
The only relationship the IPAQ-SF, PAVS, and logbook held was with moderate-to-
vigorous physical activity and BMI; however, the effect sizes were small. For specific 
aim 4, the objective physical activity levels as measured by the ActiGraph did not 
demonstrate relationships with any physical activity level and OSA severity, CPAP 
adherence, quality of life, or sleepiness. The only relationship objective physical activity 
levels did hold was with moderate-to-vigorous physical activity and BMI; however, the 
effect size was small.  
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Table 17. Research hypotheses and outcomes  
Aim  Null hypothesis  Fail 
to 
reject  
reject Findings  
1 The IPAQ-SF will not be 
moderately valid when measured 
against accelerometry for 
moderate-to-vigorous physical 
activity 
 × The IPAQ-SF demonstrated 
moderate validity when 
compared to accelerometry for 
moderate-to-vigorous physical 
activity 
1 The PAVS will not be moderately 
valid when measured against 
accelerometry for moderate-to-
vigorous physical activity 
 × The PAVS demonstrated strong 
validity when compared to 
accelerometry for moderate-to-
vigorous physical activity 
1 The logbook will not be 
moderately valid when measured 
against accelerometry for 
moderate-to-vigorous physical 
activity 
 × The log book demonstrated 
moderate validity when 
compared to accelerometry for 
moderate-to-vigorous physical 
activity 
2 The IPAQ-SF will not 
demonstrate good reliability for 
moderate-to-vigorous physical 
activity when taken two times 
over the course of 7 days 
 × The IPAQ-SF did demonstrate 
good reliability for moderate-to-
vigorous physical activity when 
taken two times over the course 
of 7 days 
2 The PAVS will not demonstrate 
good reliability for moderate-to-
vigorous physical activity when 
taken two times over the course of 
7 days 
 × The PAVS did demonstrate good 
reliability for moderate-to-
vigorous physical activity when 
taken two times over the course 
of 7 days 
3 The IPAQ-SF will not 
demonstrate moderate construct 
validity for moderate-to-vigorous 
physical activity when compared 
to factors related to OSA 
×  The IPAQ-SF did not 
demonstrate moderate construct 
validity for moderate-to-vigorous 
physical activity when compared 
to factors related to OSA 
3 The PAVS will not demonstrate 
moderate construct validity for 
moderate-to-vigorous physical 
activity when compared to factors 
related to OSA 
×  The PAVS did not demonstrate 
moderate construct validity for 
moderate-to-vigorous physical 
activity when compared to 
factors related to OSA 
3 The logbook will not demonstrate 
moderate construct validity for 
moderate-to-vigorous physical 
activity when compared to factors 
related to OSA 
×  The logbook did not demonstrate 
moderate construct validity for 
moderate-to-vigorous physical 
activity when compared to 
factors related to OSA 
4 Objective moderate-to-vigorous 
physical activity levels  from the 
ActiGraph will not correlate with 
factors related to OSA 
×  Objective moderate-to-vigorous 
physical activity levels  from the 
ActiGraph did not correlate with 
factors related to OSA 
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Chapter 5: Discussion 
Introduction  
 The main objectives of the study were to determine the validity and reliability of 
the IPAQ-SF and PAVS, as well as the validity of a physical activity logbook. 
Secondarily, the objective was to determine if the IPAQ-SF, PAVS, and logbook held 
construct validity when compared to factors related to OSA. Additionally, the 
relationship between objective physical activity levels were compared to factors related 
to OSA. As a result of conducting the study, the investigator added to the body of 
knowledge in physical activity questionnaire validity within the OSA population. The 
results from study have created a means for clinicians to get a better understanding of 
moderate and moderate to vigorous physical activity levels of OSA patients. The findings 
of the study also provide clinicians and researchers with a means to judge the 
effectiveness of protocols aimed at increasing physical activity levels in OSA patients.  
Summary of Subjects  
 The study had an uneven distribution of males (14) and females (25), but males 
and females were similar to one another in terms of age, BMI, race, OSA severity, and 
subjective and objective physical activity levels.   
Criterion Validity  
 In order to determine criterion validity, the results from the IPAQ-SF, PAVS, and 
logbook completed during the second visit were compared to the seven days of objective 
physical activity measured by the ActiGraph. With regard to the logbook, participants 
logged moderate-to-vigorous physical activity levels and did not record moderate and 
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vigorous physical activity levels individually. The validity analysis was performed with 
Pearson correlation coefficients. 
The IPAQ-SF and PAVS did not produce significant results when compared to 
vigorous physical activity levels from the ActiGraph. The IPAQ-SF over predicted 
vigorous physical activity by 120.1 ± 403.3 minutes per week while the PAVS over 
predicted vigorous physical activity levels by 44.5 ± 229.9 minutes per week. These 
results indicate that the IPAQ-SF and PAVS may not be accurate in assessing vigorous 
physical activity.  
When analyzing the validity of moderate physical activity levels, both the IPAQ-
SF and PAVS produced significant results when compared to the ActiGraph. While both 
the IPAQ-SF and PAVS produced significant results, only the PAVS had an acceptable 
effect size. The IPAQ-SF over predicted moderate physical activity by 223.7 ± 446.3 
minutes per week while the PAVS over predicted moderate physical activity by 2.3 ± 114 
minutes per week. These results indicate that the PAVS may be the most accurate 
questionnaire for determining moderate physical activity levels in OSA patients. 
When analyzing the validity of moderate-to-vigorous physical activity levels, the 
IPAQ-SF, PAVS, and logbook all produced significant results when compared to the 
ActiGraph. While all subjective forms of physical activity estimation produced 
significant results with at least moderate effect sizes, the PAVS was the only 
questionnaire to possess a strong effect size. The IPAQ-SF over predicted moderate-to-
vigorous physical activity levels by 345.9 ± 710 minutes per week, while the PAVS over 
predicted moderate to vigorous physical activity levels by 46.8 ± 248.8 minutes per week, 
and the logbook over predicted moderate-to-vigorous physical activity by 191.2 ± 491.6 
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minutes per week. These results indicate that the IPAQ-SF, PAVS, and logbook may all 
be used to determine moderate-to-vigorous physical activity levels of OSA patients; 
however, the PAVS will provide the most precise estimations.   
The results of aim 1 provide strong support that the PAVS may be the more valid 
of the two questionnaires for examining moderate and moderate-to-vigorous physical 
activity levels within an overweight and sedentary OSA population. These results are 
somewhat counterintuitive because the PAVS is a less descriptive questionnaire than the 
IPAQ-SF; however, the IPAQ-SF significantly over predicts all physical activity types 
when compared to the PAVS. 
The IPAQ-SF over predicting physical activity levels is not unique to the current 
study. Numerous studies have provided evidence that the IPAQ-SF tends to over-predict 
physical activity (Dinger et al., 2006; Grimm et al., 2012; Igelstrom et al., 2013). A study 
by Igelstrom and colleagues (2013) examined the validity of the IPAQ-SF within the 
OSA population and found that the IPAQ-SF over predicted moderate-to-vigorous 
physical activity by over five hours per week, which is very similar to the current study.  
In considering possibilities for why the IPAQ-SF tends to over-predict physical 
activity levels, it is possible that the wording does not produce correct physical activity 
intensity interpretations by OSA patients. This assertion is made by examining the results 
of the PAVS, which was taken almost simultaneously with the IPAQ-SF and produced 
drastically lower physical activity level estimations. The wording of the IPAQ-SF should 
be examined to determine if it is in fact that reason for significant over predictions.  
Another possibility for why the IPAQ-SF significantly over predicts physical 
activity levels may be its organization. The IPAQ-SF requires participants to determine 
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moderate and vigorous physical activity separately while the PAVS requires participants 
to think about total physical activity levels as a whole before stratifying them into 
moderate and vigorous. It is possible that this organization causes participants to double 
list physical activity. On more than one occasion during the study, participants expressed 
that they had listed physical activity in incorrect sections after reading the entire 
questionnaire. Despite making these comments, some participants did not erase what they 
had written previously. Future research should examine if reading the entire IPAQ-SF 
prior to completing it reduces over prediction of physical activity levels.   
The previous two assertions are further supported when analyzing the results from 
the logbook. The participant’s direct personal interpretation of physical activity over 
predicted moderate-to-vigorous physical activity levels by 191.2 minutes a week, which 
is similar to the IPAQ-SF which over predicted moderate-to-vigorous physical activity by 
345.8 minutes a week. This provides further evidence that OSA patients, particularly 
those who are overweight or obese and have moderate to severe OSA may not have a 
strong comprehension of what moderate to vigorous physical activity entails. 
Making a direct minute by minute comparison of the validity of the present study 
to previous research is difficult due to recent changes in Physical Activity Guidelines for 
Americans (Piercy et al., 2018). Previously, recommendations were that moderate-to-
vigorous physical activity only count towards total weekly activity if done in at least 10-
minute bouts (Piercy et al., 2018). This recommendation changed in 2018 to allow for all 
bouts of activity, regardless of the length, to count towards total weekly physical activity 
(Piercy et al., 2018). Most research prior to 2018 examining the validity of the IPAQ-SF, 
PAVS, or logbooks abided by the previous guidelines and included moderate-to-vigorous 
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physical activity from accelerometry only if it met the criteria of being done in 10-minute 
bouts or more (Ball et al., 2012; Dinger et al., 2006; Hagstromer et al., 2006; Igelstrom et 
al., 2013).  Considering the new recommendations, the current study included all 
moderate-to-vigorous physical activity regardless of bout length. This makes a direct 
minute by minute comparison of previous validity research to the current study 
impossible. 
Reliability  
In order to determine test retest reliability, the results from the IPAQ-SF and 
PAVS from the first visit were compared to the results from the second visit, which 
occurred seven days later. The analyses were done using intraclass correlation 
coefficients.  
With regard to the IPAQ-SF, reliability for vigorous and moderate-to-vigorous 
physical activity was good with estimations increasing by 3.1 ± 246 and 109.2 ± 627.8 
minutes per week from the first to the second visit, respectively. Reliability for moderate 
physical activity was poor with estimations increasing by 106.2 ± 527 minutes per week 
from the first to the second visit. These results are similar to previous studies which have 
examined the IPAQ-SF and found it to have moderate to good reliability (Craig et al., 
2002; Dinger et al., 2006; Hallal et al. 2004). Similar to the findings of the current study, 
a study by Dinger and colleagues (2006) found that the IPAQ-SF is moderately (0.71) 
reliable for moderate-to-vigorous physical activity and produces increases in estimations 
of moderate and vigorous physical activity the second time it is taken. It is difficult to 
ascertain why the IPAQ-SF caused increased physical activity estimations during the 
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second visit. Future research should investigate this phenomenon further within the OSA 
population.  
With regard the PAVS, reliability for vigorous physical activity was excellent and 
estimations decreased by 23.8 ± 115.2 minutes per week from the first to the second visit. 
Reliability for moderate physical activity was also excellent and estimations increased by 
14.1 ± 89.3 minutes per week from the first to the second visit. Lastly, reliability for 
moderate-to-vigorous physical activity was also excellent and estimations decreased by 
8.6 ± 100.3 minutes per week from the first to the second visit. Since the PAVS is a 
relatively new physical activity questionnaire, few studies have examined its reliability. 
We have identified three studies that found the PAVS to have good to excellent reliability 
(Ball et al., 2012; Fowles et al., 2017). A study by Fowles and colleagues (2017) found 
the PAVS to have good reliability (.83) for moderate-to-vigorous physical activity when 
examined two times within an overweight and sedentary population.  
The results indicate that the degree of reliability varies significantly between the 
IPAQ-SF and PAVS. The IPAQ-SF can be assumed to produce at least good reliability 
for vigorous and moderate-to-vigorous physical activity while the PAVS can be expected 
to produce excellent reliability for all physical activity types. The IPAQ-SF provides 
many different examples of activities that constitute moderate-to-vigorous intensity, 
while PAVS provides only one example for each. It is possible that many different and 
potentially conflated examples of types of activities by the IPAQ-SF produces differing 
results from one time to the next, whereas one example for each type of activity provided 
by the PAVS produces similar results.  
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Construct Validity  
 In order to determine construct validity of the IPAQ-SF, PAVS, and logbook, the 
results of each were compared to factors related to OSA such as OSA severity, quality of 
life, BMI, sleepiness, and CPAP adherence. This comparison was made using Spearman 
correlation coefficients.  
 With regard to the IPAQ-SF, significant relationships were found between BMI 
and moderate physical activity (ρ = -.268) as well as moderate-to-vigorous physical 
activity (ρ = -.279). These results are similar to previous research, which has examined 
the relationship between the IPAQ-SF and BMI (Hagstromer et al., 2006). A study 
similar to the current study by Hagstromer and colleagues (2006) recruited 46 adults and 
examined the relationship between the IPAQ-SF and BMI and found almost identical 
results in that significant relationships existed between moderate and moderate-to-
vigorous physical activity and BMI but held low effect sizes in ρ = -0.27 and ρ = -0.25, 
respectively.  
 The PAVS was similar to the IPAQ-SF in that it only held significant 
relationships with BMI for moderate-to-vigorous physical activity (ρ = -0.273) and 
vigorous (ρ = -0.331) physical activity. These results are similar to a large population 
study, which examined 34,712 patients within a hospital system and found a significant 
relationship between the results of the PAVS and BMI (Ball et al., 2012). 
  The physical activity logbook was identical to the IPAQ-SF and PAVS in that it 
did not hold relationships with factors related to OSA other than with BMI. The logbook 
held significant relationships with moderate-to-vigorous physical activity (ρ = -0.343) 
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and BMI. To the author’s knowledge, no previous study has examined construct validity 
of a physical activity logbook and BMI.  
 A relationship between physical activity estimation and BMI is to be expected as 
the relationship between physical activity and BMI has been well document by numerous 
studies over the previous decades (Piercy et al., 2018). Interestingly, the current study 
found that the IPAQ-SF, PAVS, and logbook held no relationship with factors related to 
OSA such as OSA severity, quality of life, sleepiness, and CPAP adherence. There are 
many possibilities as to why no relationship was found between these variables.  
The study hypothesized that there would be an inverse relationship between the 
amount of estimated physical activity and OSA severity. Studies have demonstrated that 
when people gain weight, the likelihood of developing OSA increases, and when excess 
body weight is lost, the severity of OSA tends to decrease (Coughlin et al., 2004; Quan et 
al., 2007; Redline et al., 2003; young et al., 1993; Strohl & Redline, 1996). Considering 
these facts, we assumed that those who were more physically active would have less 
severe OSA, however, this relationship was not found.  
The study hypothesized that there would a linear relationship between physical 
activity levels and the quality of life of the participants. Previous research has 
demonstrated that those with OSA are at higher risk for depression and typically have 
many comorbidities such as hypertension, diabetes, high cholesterol, heart disease, and 
obesity (Peppard et al., 2000; Peker et al., 2006; Punjabi & Polotsky, 2006). A physically 
active lifestyle has been demonstrated to improve many of these health issues 
(Giebelhaus et al. 2000; Ueno et al., 2009; Kline et al., 2011; Sengul et al., 2011). Due to 
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these facts, we believed that participants who were more physically active would have a 
higher quality of life, however, no relationship was found.  
The study hypothesized that there would be a linear relationship between physical 
activity levels and CPAP adherence. No previous research has specifically examined this 
relationship but we believed there might be a relationship because those who are more 
physically active tend to be more disciplined which may make them more likely to adhere 
to CPAP (Duckworth et al., 2010). Ultimately, no relationship was found between 
physical activity levels and CPAP adherence.  
The study hypothesized that there would be an inverse relationship between 
physical activity levels and sleepiness. Previous research has demonstrated that as OSA 
severity increases, so does sleepiness (Seneviratne and Puvanendran, 2004). This 
relationship makes sense because more severe OSA typically translates into more 
arousals from sleep and lower blood oxygen saturation. These side effects experienced in 
more severe OSA typically result in patients experiencing poorer quality sleep and more 
sleepiness during the day (Eckert & Malhotra, 2008; Seneviratne and Puvanendran, 
2004). We hypothesized that there might be a relationship between physical activity 
levels and sleepiness because people with higher BMIs tend to have more severe OSA 
which tends to produce higher sleepiness scores (Seneviratne and Puvanendran, 2004). 
Previous research has also demonstrated a relationship between lower physical activity 
levels and increased sleepiness scores within the OSA population (Basta et al., 2008). 
Despite our rationale and previous research supporting the hypothesis, no relationship 
was found between physical activity levels and sleepiness. 
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Many possibilities may account for why no relationship was found between 
physical activity and sleepiness in the recruited population. One possibility may be 
directly related to another finding in the study which was that there is no relationship 
between physical activity and CPAP adherence. This finding demonstrates that increased 
physical activity levels do not translate into greater adherence to CPAP within an 
overweight and obese OSA population. It has been previously demonstrated that as 
patients become more adherent to CPAP, their sleepiness levels decrease (Antic et al., 
2011). If the results of the current study are accurate and more physically active patients 
do not adhere better to CPAP then it cannot be expected that an overweight and obese 
OSA population will have lower sleepiness scores.  
Exploratory  
 In order to determine if there was a relationship between objective physical 
activity levels as measured by the ActiGraph and factors related to OSA, the results from 
the ActiGraph were compared to OSA severity, quality of life, BMI, sleepiness, and 
CPAP adherence. This comparison was made using Spearman correlation coefficients. 
The results demonstrated that objective physical activity levels did not hold significant 
relationships with OSA severity, quality of life, sleepiness, or CPAP adherence. The only 
relationship that objective physical activity levels held was with BMI. 
 The significant relationships found were between objective moderate-to-vigorous 
physical activity (ρ = -0.320) and objective moderate physical activity (ρ = -0.335). 
These results are in line with previous studies which have examined objective physical 
activity and BMI (Hagstromer et al., 2007). A large population study by Hagstromer and 
colleagues (2007) recruited 1114 adults and tracked physical activity of participants using 
81 
accelerometry for seven consecutive days. The study found a significant relationship 
between lower moderate-to-vigorous physical activity levels and higher BMI scores.  
Limitations 
 Limitations exist within the study. In terms of recruitment, diagnosis of 
participants took place at different clinics by different interpreting doctors during 
different points in time. It is possible that varying degrees of severity were diagnosed in 
participants solely due to the fact that diagnosis occurred at different clinics, which use 
different systems and have different interpreting doctors. Obstructive sleep apnea severity 
may also have changed over time since diagnosis in some participants occurred years 
prior to study. Both of these factors may have influenced the results, especially with 
regard to construct validity of the IPAQ-SF, PAVS, logbook, and objective physical 
activity levels. If the study were to have taken place at one clinic, where one interpreting 
doctor diagnosed all participants at a similar point in time, different results may have 
observed.      
 In terms of the population recruited, the current study focused on an overweight 
and obese OSA population with moderate to severe OSA and low levels of physical 
activity. For this reason, it is possible that other OSA populations, such as those who are 
of a normal weight or are more physically active, may have produced different results.  
 In terms of physical activity, a limitation may be due to the period of time in 
which the study took place. The study began in the spring and was completed at the 
beginning of the summer. A study by Tucker and Gilliland (2007) found that the spring 
and summer months are when people tend to more physically active. If the study was 
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done during a different season or throughout the course of an entire year, it is possible 
that different results for objective physical activity would have been found. 
Future Implications  
 The study found differences in the validity and reliability of the three 
questionnaires. Both the IPAQ-SF and physical activity logbook held moderate validity 
and reliability for determining moderate-to-vigorous physical activity, while the PAVS 
held excellent validity and reliability for determining both moderate and moderate-to-
vigorous physical activity. These results indicate that while the IPAQ-SF, PAVS, or 
logbook would all be reasonable options for determining moderate-to-vigorous physical 
activity, the PAVS is the best choice for precisely determining physical activity levels 
within the OSA patients who participated in this study. 
As noted in chapter II, despite the fact that physical activity questionnaires are 
commonly used within clinical practice and in research, no questionnaire has been 
validated within the OSA population. The study was unique in the fact that it addressed 
this issue and now provides initial evidence that supports a reliable and valid 
questionnaire for clinicians and researchers to utilize in the future with individuals who 
suffer from OSA. By providing a valid, inexpensive, and time efficient tool for the 
determination of moderate-to-vigorous physical activity levels, clinicians will be able to 
better serve their OSA patients by having a more complete understanding of their overall 
physical health. This will allow for more appropriate and catered treatment of their OSA, 
as well as a means to determine the effectiveness of protocols aimed at increasing 
physical activity levels. The questionnaire will also allow researchers to better study and 
understand the relationships between physical activity levels and factors related to OSA.     
83 
Future Directions 
 There are many avenues for future research with regard to physical activity 
questionnaires. Large population studies should be done using the PAVS to better 
understand the relationship between OSA and moderate to vigorous physical activity 
levels. It is well documented that increased physical activity is beneficial for decreasing 
the severity of OSA on an individual level, but how specific physical activity levels relate 
to OSA as a whole is an area that needs further exploration (Giebelhaus et al. 2000; Ueno 
et al., 2009; Kline et al., 2011; Sengul et al., 2011). While the current study attempted to 
address this, the sample size was small and limitations were present. This information 
would provide clinicians with a means to tailor physical activity recommendations and it 
would provide researchers with a better idea of what types of physical activity 
interventions to examine.  
 Future research should also examine the utility of the questionnaires for 
increasing physical activity within OSA patients or patients at risk for developing OSA. 
One of the best models for predicting whether people will engage in activities that are 
beneficial for their health, or in this case physical activity, is the Health Belief Model 
(Janz and Becker, 1984). One major construct of the Health Belief Model is that people 
must have a perceived threat in order to take action. In the case of OSA, this would 
involve patients understanding the serious threat to overall health that OSA presents as 
well as what makes them susceptible to developing OSA. Increasing awareness of these 
facts would involve counseling of patients by researchers or clinicians.  
 After a perceived threat for a health disorder is established, the Health Belief 
Model states that individuals must understand the benefits of engaging in activities that 
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will decrease the likeness of developing or worsening of a health disorder. With regard to 
physical activity and OSA, this would involve informing OSA patients about how 
physical activity is capable of reducing the chance of developing or worsening existing 
OSA. Similar to perceived threat, counseling by clinicians or researchers would need to 
be applied in order for OSA patients to understand the benefits of physical activity. 
 Lastly, and most importantly with regard to the current study, the Health Belief 
Model states that there must be a cue to action (Janz and Becker, 1984). As discussed 
previously, patients must understand that they are susceptible to OSA and it has serious 
health consequences. They must also understand that engaging in physical activity 
reduces the likelihood of developing or worsening OSA, but they also must have a cue to 
action otherwise they are not likely to engage in physical activity (Janz and Becker, 
1984). A validated physical activity questionnaire such as the PAVS would allow OSA 
patients to get an immediate understanding of their current physical activity levels and 
this may serve as a que to action and increase the likeness of OSA patients engaging in 
physical activity. Whether or not the PAVS can used within this model to increase 
physical activity levels of OSA patients should be explored. A schematic of how the 
PAVS may be integrated within the Health Belief Model is found in figure 7.  
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Figure 7. Utilization of the PAVS within the Health Belief Model 
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Appendix 1: Recruitment Flyer 
  
Obstructive sleep apnea (OSA) is a highly prevalent, yet frequently 
undiagnosed sleep disorder. Evidence continues to mount linking OSA to 
numerous health concerns, including diabetes, high blood pressure, 
heart attack, and stroke.  Research has demonstrated that increased 
physical activity and exercise may be a novel treatment for decreasing 
the severity of OSA, although the relationship between physical activity 
levels and OSA remains poorly understood.   
 
Research Study 
Researchers at the IUPUI Departments of 
Kinesiology are conducting a research study to 
determine whether a physical activity 
questionnaire is accurate within the OSA 
population. If you are a male or female (age 18-
65) and have been diagnosed with moderate-
severe OSA and are not currently being treated 
with or actively using CPAP, you may qualify for this research study.   
 
The study consists of wearing a hip-worn activity tracker for seven days 
and answering three physical activity questionnaires before, and again 
after, the seven days of activity tracking.   
For additional information about this study, please contact Max 
Adolphs by email at madolphs@iu.edu. 
 
Are Physical Activity Questionnaires 
Valid in Patients with Obstructive 
Sleep Apnea? 
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Appendix 2: Email Script  
THE VALIDITY AND RELIABILITY OF THE PAVS AND IPAQ AS PHYSICAL 
ACTIVITY ASSESSMENT TOOLS IN PATIENTS WITH OBSTRUCTIVE 
SLEEP APNEA  
The IUPUI Department of Kinesiology is seeking volunteers to participate in 
a study to evaluate the accuracy of physical activity questionnaires in 
individuals diagnosed with Obstructive Sleep Apnea (OSA).  If you are 
between 18 and 65 years of age, have a diagnosis of moderate-severe OSA, 
and are not currently being treated with or actively using continuous positive 
airway pressure, you may qualify for the study.  For additional information, 
contact Max Adolphs at madolphs@iu.edu.   
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Appendix 3: All IN for Health Registry Email 
 
Dear <<Contact name>>, 
Thank you for your participation in All IN for Health’s Volunteer Registry! 
We are contacting you because you may be interested in participating in a study 
being conducted by the IUPUI School of Health and Human Sciences. The study, 
called The Validity and Reliability of the PAVS and IPAQ-SF as Physical Activity 
Assessment Tools in Patients with Obstructive Sleep Apnea, wants to determine 
whether two physical activity questionnaires are reliable and valid within the 
Obstructive sleep apnea (OSA) population. 
In order to participate in the study, you must: 
a. be 18-65 years of age 
b. diagnosed with obstructive sleep apnea 
 
If you are eligible, and you decide to participate, you will be asked to meet with someone from 
the study team at a convenient location. Specifically, you will be asked to wear a hip-worn 
activity tracker for seven days and answer two physical activity questionnaires before, and 
again after, the seven days of activity tracking. For your time, you will be compensated with 
Visa gift cards: $50 after completion of the first visit and another $100 after completion of the 
second visit. 
If you have any questions or would just like more information, please contact Max 
Adolphs by email at madolphs@iu.edu.  
 
Thank you for your time and continued interest and support of our research. 
Warm regards, 
The All IN for 
Health Team 
www.allin4healt
h.info 
chat@allin4heal
th.info 
1-888-264-0005 
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Appendix 4: IPAQ-SF 
 
INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE 
 
We are interested in finding out about the kinds of physical activities that people 
do as part of their everyday lives.  The questions will ask you about the time you 
spent being physically active in the last 7 days.  Please answer each question 
even if you do not consider yourself to be an active person.  Please think about 
the activities you do at work, as part of your house and yard work, to get from 
place to place, and in your spare time for recreation, exercise or sport. 
 
Think about all the vigorous activities that you did in the last 7 days.  Vigorous 
physical activities refer to activities that take hard physical effort and make you 
breathe much harder than normal.  Think only about those physical activities that 
you did for at least 10 minutes at a time. 
 
1. During the last 7 days, on how many days did you do vigorous physical 
activities like heavy lifting, digging, aerobics, or fast bicycling?  
 
_____ days per week  
 
   No vigorous physical activities  Skip to question 3 
 
 
2. How much time did you usually spend doing vigorous physical activities on one of those 
days? 
 
_____ hours per day  
_____ minutes per day  
 
  Don’t know/Not sure  
 
 
Think about all the moderate activities that you did in the last 7 days.  Moderate 
activities refer to activities that take moderate physical effort and make you 
breathe somewhat harder than normal.  Think only about those physical activities 
that you did for at least 10 minutes at a time. 
 
 
3. During the last 7 days, on how many days did you do moderate physical 
activities like carrying light loads, bicycling at a regular pace, or doubles 
tennis?  Do not include walking. 
 
_____ days per week 
 
   No moderate physical activities  Skip to question 5 
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4. How much time did you usually spend doing moderate physical activities on one of 
those days? 
 
_____ hours per day 
_____ minutes per day 
 
  Don’t know/Not sure  
 
 
Think about the time you spent walking in the last 7 days.  This includes at work 
and at home, walking to travel from place to place, and any other walking that 
you have done solely for recreation, sport, exercise, or leisure. 
 
5. During the last 7 days, on how many days did you walk for at least 10 
minutes at a time?   
 
_____ days per week 
  
   No walking     Skip to question 7 
 
 
6. How much time did you usually spend walking on one of those days? 
 
_____ hours per day 
_____ minutes per day  
 
  Don’t know/Not sure  
 
 
The last question is about the time you spent sitting on weekdays during the last 7 days.  
Include time spent at work, at home, while doing course work and during leisure time.  This may 
include time spent sitting at a desk, visiting friends, reading, or sitting or lying down to watch 
television. 
 
7. During the last 7 days, how much time did you spend sitting on a week day? 
 
_____ hours per day  
_____ minutes per day  
 
  Don’t know/Not sure  
 
 
This is the end of the questionnaire, thank you for participating. 
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Appendix 5: PAVS 
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Appendix 6: Epworth Sleepiness Scale 
Epworth sleepiness scale 
How likely are you to doze off or fall asleep during the following situations, 
in contrast to just feeling tired? 
For each of the situations listed below, give yourself a score of 0 to 3, where 
0 = Would never doze; 1 = Slight chance; 2 = Moderate chance; 3 = High chance. 
Work out your total score by adding up your individual scores for situations 1 to 8. (If you have 
not been in the following situations recently, think about how you would have been affected.) 
Situation Score 
Sitting and reading    
Watching television   
Sitting inactive in a public place (e.g. a theatre/meeting)   
As a passenger in a car for an hour with no break   
Lying down in the afternoon (when possible)   
Sitting and talking to someone   
Sitting quietly after lunch without alcohol   
In a car, while stopped for a few minutes in traffic   
Total   
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Appendix 7: Quality of Life Questionnaire 
1. Would you say that in general your health is; Excellent, Very good, Good, 
Fair or Poor? 
 
2. Now thinking about your physical health, which includes physical illness and 
injury, for how many days during the past 30 days was your physical health 
not good? 
 
3. Now thinking about your mental health, which includes stress, depression, 
and problems with emotions, for how many days during the past 30 days was 
your mental health not good? 
 
4. During the past 30 days, for about how many days did poor physical or 
mental health keep you from doing your usual activities, such as self-care, 
work, or recreation? 
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Appendix 8: Cognitive Impairment Questionnaire 
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Appendix 9: Informed Consent  
INDIANA UNIVERSITY INFORMED CONSENT STATEMENT FOR 
 
The Validity and Reliability of the PAVS and IPAQ-SF as Physical Activity 
Assessment Tools in Patients with Obstructive Sleep Apnea  
You are invited to participate in a research study determining the validity and reliability 
of two physical activity questionnaires within the obstructive sleep apnea population. 
You were selected as a possible subject because you are male or female, between the ages 
of 18-65 years old and have been diagnosed with moderate to severe obstructive sleep 
apnea (OSA). Please read this form and ask any questions you may have before agreeing 
to be in the study. 
  
The study is being conducted by Max Adolphs, Indiana University-Purdue University- 
Indianapolis, School of Health and Human Sciences and Anthony Kaleth Indiana 
University-Purdue University- Indianapolis, School of Health and Human Sciences   
 
STUDY PURPOSE 
The purpose of this study is to see if scientists can use the International Physical Activity 
Questionnaire Short Form (IPAQ-SF) and Physical Activity Vital Sign (PAVS) 
questionnaire in the OSA population to accurately see how physically active people are.  
 
NUMBER OF PEOPLE TAKING PART IN THE STUDY 
If you agree to participate, you will be one of 50 subjects who will be participating in this 
research. 
 
PROCEDURES FOR THE STUDY 
If you agree to be in the study, you will do the following things: 
During the first visit, which is taking place here today, you will be asked to: 
• You will first complete an authorization form that will allow the research team to 
access your medical records.  
• You will then complete the IPAQ-SF and PAVS, which are both short 
questionnaires that will ask you questions about how much physical activity you 
have done over the past week as well as the intensity of the physical activity.  
• You will also complete a cognitive impairment and quality of life questionnaire.  
o The cognitive impairment questionnaire will ask very straightforward 
questions such as your age and answers to addition and subtraction math 
questions.  
o The quality of life questionnaire will ask you to rate your level of health.  
• You will then be fitted with a belt around the waist that will serve as the 
attachment point for the ActiGraph. The ActiGraph is an activity tracker that will 
record the amount of physical activity you do over the course of the next week. 
You will keep the Actigraph in a pouch, which exists on the belt on top of your 
right hip. You will need make sure the Velcro flap is pointed downward and 
away from your body.  
97 
o You will wear the Actigraph during all waking hours for the next seven 
consecutive days, except when showering, bathing, or swimming. You 
will remove the Actigraph when going to bed at night and record what 
time you put on and removed the Actigraph each day onto a log sheet. 
o You will record the amount and intensity of physical activity you do over 
the course of the week on a log sheet  
o You will record how much you use your CPAP each night on a log sheet  
 
Second visit. Following the seven days, you will meet with a researcher a second time at 
a mutually agreed upon location to return the Actigraph and complete the IPAQ and 
PAVS a second time.  
 
RISKS OF TAKING PART IN THE STUDY 
While on the study, the potential risks (side effects and/or discomforts) are: 
Risks associated with this study are minimal. You are being asked to live normally with 
no increases or decreases in physical activity levels other than those typically performed 
during a normal week.   
 
If you feel uncomfortable answering any of the questions, then you do not need to 
answer. In that case, please skip the question and answer the next.  
There is a small risk of loss of confidentiality. 
 
BENEFITS OF TAKING PART IN THE STUDY 
There are no direct benefits to participation but we hope that your data will contribute 
valuable information regarding the accuracy of the PAVS and IPAQ as physical activity 
assessment tools within the OSA population. 
 
ALTERNATIVES TO TAKING PART IN THE STUDY 
Participation in this study is voluntary and there are no alternative treatments or 
procedures that might be advantageous to you, should you choose not to participate in 
this study. 
 
CONFIDENTIALITY 
Efforts will be made to keep your personal information confidential.  We cannot 
guarantee absolute confidentiality.  Your personal information may be disclosed if 
required by law.  Your identity will be held in confidence in reports in which the study 
may be published and databases in which results may be stored 
 
Organizations that may inspect and/or copy your research records for quality assurance 
and data analysis include groups such as the study investigator and his/her research 
associates, the Indiana University Institutional Review Board or its designees, the study 
sponsor and (as allowed by law) state or federal agencies, specifically the Office for 
Human Research Protections (OHRP) who may access your research records. 
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USE OF YOUR INFORMATION IN FUTURE RESEARCH 
Information collected from you for this study may be used for future research studies or 
shared with other researchers for future research.  If this happens, information which 
could identify you will be removed before any information is shared.  Since identifying 
information will be removed, we will not ask for your additional consent. 
 
COSTS 
There are no additional costs related to participating in this study.  Expenses that result 
from transportation to a mutually agreed upon location will be your responsibility.  
 
PAYMENT 
You will receive payment for taking part in this study. At the completion of the first visit, 
you will receive $50 in the form of a Visa gift card, which can be used for purchases at 
any location which accepts Visa. By completing both sessions, you will receive another 
$100 in the form of a Visa gift card.  
 
CONTACTS FOR QUESTIONS OR PROBLEMS 
For questions about the study during and after business hours, contact the researcher, 
Max Adolphs.  
In the event of an emergency, you may contact Max Adolphs 
For questions about your rights as a research participant, to discuss problems, complaints, 
or concerns about a research study, or to obtain information or offer input, contact the IU 
Human Subjects Office at 800-696-2949 or irb@iu.edu. 
 
VOLUNTARY NATURE OF THIS STUDY 
Taking part in this study is voluntary.  You may choose not to take part or may leave the 
study at any time.  Leaving the study will not result in any penalty or loss of benefits to 
which you are entitled.  Your decision whether or not to participate in this study will not 
affect your current or future relations with Indiana University Purdue University 
Indianapolis.  
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SUBJECT’S CONSENT 
In consideration of all of the above, I give my consent to participate in this research 
study.  
  
I will be given a copy of this informed consent document to keep for my records.  I agree 
to take part in this study. 
 
Subject’s Printed Name:  
Subject’s Signature:  
Date:  
(must be dated by the subject) 
 
Printed Name of Person Obtaining 
Consent:__________________________________________  
 
Signature of Person Obtaining Consent:  
Date:  
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